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Abstract 
 
Isometric handgrip (IHG) training lowers resting blood pressure (BP) and 
improves heart rate variability (HRV) in hypertensives, yet neither the acute responses 
nor the effects of training on these responses are known. IHG training effects on 24-hr 
ambulatory BP have also yet to be examined. To address these voids, 11 hypertensive 
individuals (medicated) performed 4, 2-min IHG contractions at 30% MVC, 3x/wk for 8 
wks, and 9 age-matched medicated hypertensives served as controls. At baseline, mid- 
and post-training, BP and HRV were assessed prior to and following acute IHG, with BP 
monitored for 22 hrs post-IHG. Resting and ambulatory BP were measured on a 
separate day. Acute nor chronic IHG exercise altered resting BP or HRV, and 24-hour 
ambulatory BP was unchanged with training (all P > 0.05). These findings suggest that 
IHG (acute and chronic) does not influence BP or HRV in our population of well-
controlled medicated hypertensives. 
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1.1 Hypertension 
1.1.1 Introduction 
Hypertension (HT) is a medical condition characterized by sustained levels of 
high arterial blood pressure (ABP). 1 in 5 Canadians has HT, yet only 43% of people with 
HT are aware of their condition (39), thus it is often referred to as “the silent killer”.  HT 
greatly increases the risk of developing cardiovascular disease (CVD) (89), which is the 
leading cause of death in Canada (107). HT is directly responsible for 75% of all stroke 
cases (56). Though significant achievements in the treatment and prevention of HT have 
been made, the disease remains a prominent health problem in Canada.  
1.1.2 Arterial Blood Pressure – Neural, Local and Hormonal Regulation  
To better understand the complex pathophysiology of HT, we must first 
understand ABP itself and the key regulatory mechanisms that sustain ABP in a healthy 
state. 
A complete cardiac cycle (1 beat of the heart) exerts 2 distinct pressures on the 
body’s arterial system:  systolic and diastolic. The pressure the blood exerts on the 
arterial system during a cardiac contraction is known as systolic ABP (SBP).  In order for 
blood flow to occur, it must move from an area of high pressure to an area of low 
pressure. Therefore, SBP must be greater than the resistance provided by the arterial 
side of the circulatory system to allow an adequate supply of blood flow to meet the 
demands and needs of the body’s organs and tissues. Diastolic ABP (DBP), however, 
represents the pressure blood exerts on the arterial system when the heart is in the 
relaxation phase of the cardiac cycle. These two values are most commonly recorded as 
SBP/DBP, with normal ABP being ≤120 mmHg /80 mmHg (115).  
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ABP is a tightly regulated system, maintained primarily through neural, local, and 
hormonal control. These control mechanisms work together to maintain ABP by 
influencing 3 main cardiovascular parameters: total peripheral resistance (TPR), heart 
rate (HR), and stroke volume (SV).  Cardiac output (CO) is the product of HR and SV 
(53), thus changes in CO affect ABP. This is also depicted in the equation for 
determining ABP, where ABP equals the product of CO and TPR (53).  
Neural Control of Arterial Blood Pressure 
 The neural control mechanism responsible for cardiovascular control, particular 
ABP, is referred to as “central command” (CC) (97). When the body experiences a 
cardiovascular stress, CC transmits efferent signals to the cardiovascular control center 
(CCC), which integrates the signals and responds by changing the balance of the 
autonomic nervous system (ANS). The ANS can be divided into the sympathetic nervous 
system (SNS) and the parasympathetic nervous system (PNS). The SNS has a 
stimulatory effect on the body, which results in an increase in TPR, HR and SV. The 
PNS, however, has a relaxing effect on the body. It decreases TPR, HR and SV. These 
systems work simultaneously, where the upregulation of one system over the other 
results in physiological changes. 
 The CCC has a very important role in ABP regulation. Not only does this region 
receive signals from CC, it also receives afferent signals from receptors located in the 
body that respond to physiological changes. These receptors include arterial 
baroreceptors, peripheral chemoreceptors and muscle afferent receptors.  
ABP is regulated by the arterial baroreceptors (103).  Arterial baroreceptors are 
stretch receptors located in the arterial wall of the carotid artery at the carotid sinus and 
aortic arch (19, 57). Since baroreceptors are not pressure sensors, but rather stretch 
receptors, when pressure exerted on the arterial walls changes, the receptors respond 
 4 
not directly to the pressure change, but rather to the conformational change the pressure 
induces in the receptor. The CCC is responsible for receiving and responding to these 
afferent impulses, which adjusts the ANS to maintain homeostasis.  
Peripheral chemoreceptors are sensory receptors responsible for detecting low 
oxygen levels in arterial blood (31, 94), as well as high carbon dioxide and hydrogen ion 
concentrations (31). These receptors are located in the carotid and aortic bodies and 
send afferent signals to the CCC when these conditions occur. The CCC responds to 
these signals by altering the ANS, increasing the influence of the SNS to increase ABP, 
in order to sustain adequate levels of oxygen and decrease levels of carbon dioxide and 
hydrogen ions (31).    
 Muscle afferent sensory receptors are activated mainly during exercise and send 
afferent signals to the CCC to alter autonomic activity (46). There are two main sensory 
receptors: 1) mechanoreceptors, which detect stretch in the contracting muscles and 2) 
metaboreceptors, which detect metabolic changes within the tissue (71). 
Mechanoreceptors and metaboreceptors send afferent signals to the CCC, which in turn 
alter the ANS to regulate ABP (71). 
 Neural regulation of ABP involves many sensory receptors that communicate with 
the CCC to alter the ANS. These systems work together to maintain ABP homeostasis 
and continue to supply the body with adequate blood flow during times of cardiovascular 
stress.   
Local Control of Arterial Blood Pressure 
Local regulation of ABP involves vasoactive substances that alter blood flow to 
meet the metabolic demands of a tissue/muscle (33). Three prominent vasoactive 
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regulators responsible for these changes are potassium, adenosine triphosphate (ATP) 
derivatives, and endothelium-derived substances.   
 Potassium is a substance known to accumulate in the muscle during exercise 
and slight elevations of potassium have been shown to cause vasodilation, thus causing 
increased blood flow to target tissues (33). Potassium is a metabolic byproduct released 
from active muscles. Therefore, its accumulation in the muscle’s extracellular fluid is a 
signal to the smooth muscle to allow an increase in blood flow to compensate for the 
increased metabolic demands of the tissue.   
Derivatives of ATP, including adenosine diphosphate (ADP), adenosine 
monophosphate (AMP) and adenosine, are all vasoactive substances (33). As ATP is an 
essential component in muscle contraction, by-products of its catabolism signal an 
increased demand for blood in the exercising muscle. Therefore, when concentrations of 
these compounds accumulate, they cause vasodilatation of the vasculature, which 
increases blood flow to the exercising muscle (33).    
 Vascular smooth muscles cells (VSMCs) play an important role in ABP 
regulation. These cells control vascular tone via dilation and constriction, thus altering 
blood flow and TPR throughout the body. VSMCs form the second layer of the artery 
(tunica media), and lay adjacent to the endothelium (inner layer or intima; see Figure 1), 
and are controlled involuntarily (34,116), primarily by the autonomic nervous system. 
Hormones (e.g., catecholamines, atrial natriuretic factor) and other local chemical stimuli 
(e.g., NO, endothelin) may also modulate the contractile state of the VSMCs (116). 
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Figure 1: The cellular arrangement of an artery- endothelial cells comprise the inner 
layer or lumen of the artery (tunica interna, intima) and the second cell layer is composed 
of vascular smooth muscle cells. 
 
With respect to the latter, NO plays a role in locally-mediated vasodilation. NO is 
the most potent of the vasoactive substances (109). NO is released by the endothelium 
in response to shear stress exerted on the blood vessel walls or the presence of a 
chemical stimulus (catacholamines). NO increases the concentration of cyclic guanine 
monophosphate (cGMP), which in turn activates cGMP-dependent protein kinase. This 
protein dephosphorylates the myosin light chain (MLC) of the smooth muscle, which 
inhibits the binding of myosin and actin, thus preventing contraction and promoting 
relaxation of the VSMCs (116). Therefore, NO causes a cascade of events that leads to 
the relaxation of the VSMCs, which in turn allow the blood vessel lumen to expand. This 
expansion decreases the pressure exerted on walls of the blood vessels, and thus 
decreases resistance in the vasculature and increases blood flow.   
The vasodilatory effects of NO are counterbalanced via the action of 
vasoconstricting substances, the most powerful of which is endothelin (ET-1; the smooth 
muscle isoform). ET-1 is a compound released by the endothelial cells in response to a 
mechanical (i.e., shear stress) or chemical (i.e., angiotensin II) stimulus. There are 
specific receptors on the VSMCs that bind ET-1: ETA and ETB. When ET-1 binds to 
either of the two receptors on the VSMCs, a cascade of events occurs (93). For 
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example, ET-1 induces vasoconstriction via ETA receptor activation. The binding of ET-1 
to its receptor causes the activation of phopholipase C (PLC). Active PLC hydrolyzes the 
membrane bound protein phosphatidylinositol into two molecules: inositol triphosphate 
(IP3) and diacylglyerol. These molecules are classified as secondary messengers, as 
they relay the extracelluar signal to the inside of the cell. IP3 binds to the sarcoplasmic 
reticulum and causes it to release sequestered Ca2+. ET-1 activates voltage dependent 
Ca2+ channels on the plasma membrane causing them to open and allow an influx of 
Ca2+ into the VSMC (93). The contractile state of the VSMCs depends on intracellular 
[Ca2+] (116). When intracellular [Ca2+] increases, calmodulin and Ca2+ bind to create a 
Ca2+-calmodulin complex. This complex activates myosin light chain (MLC) kinase, which 
phosphorylates light chain myosin of the VSMCs (115). MLC phosphorylation allows 
cross-bridge formation with actin.  Myosin ATPase then breaks the high phosphate bond 
of ATP, releasing energy and thus allowing smooth muscle contraction to occur (116).  
ET-1 also acts via a negative feedback mechanism, whereby the stimulation of 
ETB receptors, located on the endothelium, triggers the release of NO (93). This 
feedback response causes the dephosphorylation of the MLC and thus promotes 
relaxation of the vasculature.  
Hormones and other chemical stimuli are also able to inhibit/promote the activity 
of MLC kinase and MLC phosphotase. For example, norepinephrine is considered a 
vasoconstrictor, as it promotes the release of Ca2+ from the sarcoplasmic reticulum, 
promoting Ca2+-calmodulin binding, which in turn causes smooth muscle contraction 
(116).  In contrast, atrial natriuretic factor (ANF) is classified as a vasodilator as it inhibits 
the myosin-actin contractile mechanism and thus promotes vessel relaxation (116).  
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Hormonal Control of Arterial Blood Pressure 
 Many hormones influence the control of ABP; including catacholamines (released 
by sympathetic and parasympathetic neurons), renin (released by the kidneys), 
aldosterone (secreted by the adrenal cortex), vasopressin (released by the pituitary 
gland), and atrial natriuretic peptide (released by the heart). These hormones work in 
conjunction with the neural and local ABP control mechanisms to maintain ABP 
homeostasis. 
 SNS neurons release epinephrine and norepinephrine (catecholamines; 
neurotransmitters), to stimulate specific cardiovascular responses. Where nerve fibers 
come into close contact with the vasculature, synapses are formed. Norepinephrine is 
released from the neuron at this synapse. When efferent impulses to these neurons 
increase, more norepinephrine is released into the synaptic cleft. Norepinephrine travels 
across the synaptic cleft and binds to vascular α-adrenergic receptors, causing 
vasoconstriction of the target cell (110). Though some of this compound binds to 
receptors on the target cell, it is a fraction of the total amount released from the 
presynaptic terminal. Most of the compound undergoes reuptake by the neural terminal, 
while another fraction enters the circulatory system. There are also receptors on the 
presynaptic terminal that are sensitive to norepinephrine. When there is an excess 
release of this neurotransmitter, some binds to the α2-adrenergic receptors located on 
the neuron, and further release of norepinephrine is inhibited. This negative feedback 
response indirectly causes vasodilatation (84).  
The outcome of epinephrine release is mediated by the type of receptor to which 
it binds and the location of the receptor. Both α and β-adrenergic receptors respond to 
epinephrine. The cardiac response to epinephrine is induced by the stimulation of β-
adrenergic receptors. This stimulation will result in increased force of contractility and 
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increased HR, which therefore increases ABP (70). Vascular α-adrenergic receptors can 
also be stimulated by epinephrine, which results in vasoconstriction. This causes an 
increase in TPR, which results in an increase in ABP (70).  
HR is also regulated by catecholamine activity. As the amount of norepinephrine 
released during the stimulation of sympathetic neurons only changes cardiac behavior 
fractionally, this pathway requires the activity of secondary messengers, cAMP (32). 
Once cAMP is formed, it stimulates β-adrenergic receptors, which causes the sinoatrial 
node to increase the rate of impulse generation, thus increasing HR (84). This increase 
in HR results in an increase in ABP. 
The parasympathetic neurons have only a small effect on vascular resistance. 
These nerves only innervate blood vessels in the sacral and cranial regions of the body, 
which results in little influence by these neurons (57).  Therefore, TPR created by this 
vasculature only minimally affects ABP. 
Acetylcholine is the neurotransmitter released from parasympathetic nerves. 
When acetylcholine binds to muscarinic receptors, located in the cardiac cell membrane, 
it causes a decrease in myocardial contractility (8). A decrease in force production by the 
myocardium results in decreased ABP. Binding of acetylcholine does not directly 
decrease myocardial contractility, but rather inhibits adenylyl cyclase (8). This causes 
intracellular cAMP concentrations to decrease, which reduces calcium channel 
phosphorylation, causing less calcium channels to open (8). This results in a smaller 
influx of calcium, which in turn reduces the amount of calcium released from the 
sarcoplasmic reticulum via calcium induced calcium release. This cascading effect 
ultimately decreases myocardial contractility. HR is also influenced by parasympathetic 
activity. The stimulation of the parasympathetic nerves releases acetylcholine into the 
heart, slowing the rate of depolarization. A slower depolarization rate causes HR to 
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decrease, resulting in an ABP reduction (114). The sinoatrial node can also become 
hyperpolarized when stimulated by parasympathetic nerves. This results in the sinoatrial 
node taking a longer time to reach threshold potential, thus slowing the rate of 
depolarization and therefore decreasing HR and ABP.  
The kidneys are recognized as having the most control over long-term ABP 
regulation. They accomplish this through blood volume regulation and vascular tone. 
Renin begins the cascade effect by which hormones modulate this system (115). 
 Renin is a glycoprotein enzyme synthesized in the kidneys. Renin is secreted, via 
exocytosis, and interacts with angiotensinogen. Angiotensinogen is cleaved by renin to 
form angiotensin I. Angiotensin converting enzyme cleaves angiotensin I, which is the 
inactive form of the protein, into angiotensin II, which is the active form of the protein 
(11). Angiotensin II is a potent vasoconstrictor, and thus will have the effect of increasing 
ABP by increasing TPR.  
 Angiotensin II stimulates the secretion of aldosterone from the adrenal cortex. 
The kidney responds to aldosterone by increasing the reuptake of sodium by the body  
(70). When sodium is retained, water follows this change in ion concentration, increasing 
fluid volume in the body. This will have a net effect of increasing blood volume, which will 
increase ABP.  
 Thirst is a mechanism by which the body is able to influence fluid intake to 
increase or decrease total blood volume. As blood volume contributes to ABP, thirst can 
play a role in ABP. The hormone responsible for the stimulation of thirst is angiotensin II. 
Once again, this hormone acts to increase ABP by means of increasing fluid intake.  
Arterial baroreceptors have an inhibitory effect on thirst, which helps to decrease ABP 
(69). 
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 When ABP is below normal values, vasopressin is released into systemic 
circulation by the pituitary gland (41). This hormone has 2 specific roles in regulating 
ABP. First, it is able to induce vasoconstriction in the arteries. As discussed earlier, 
vasoconstriction of the arteries will cause ABP to increase. The second role of 
vasopressin is fluid balance regulation (18).  Vasopressin changes fluid balance by 
increasing the amount of water excreted by the kidneys. 
 There are multiple types of receptors with which vasopressin can interact. 2 
receptors are of primary concern, as their stimulation induces changes in ABP. V1 and V2 
are the receptors of interest. V1 vascular- termed V1R- is located in the smooth muscle 
cells of the vascular tissue. The stimulation of these receptors causes vasoconstriction of 
the vasculature.  V2 renal- termed V2R- is located in kidney cells and stimulation of these 
receptors causes an increase in water excretion into the urine (42). When water 
excretion increases, total fluid volume within the body decreases, and subsequently ABP 
decreases.  
Cardiac atrial cells release atrial natriuretic peptide when the atria experience an 
increase in pressure (114). Atrial natriuretic peptide has the opposite effect of 
aldosterone. This peptide acts on the kidneys to decrease sodium reabsorption. The 
efflux of sodium will pull water into the urine, allowing the kidneys to decrease blood 
volume to alleviate rising ABP (70). Atrial natriuretic peptide also has an inhibitory effect 
on other hormones. Renin, aldosterone and vasopressin secretion are inhibited by atrial 
natriuretic peptide. This inhibition results in a decrease of ABP (4).  
1.1.3 Methods of Measuring Arterial Blood Pressure 
 The most accurate way to measure ABP requires an invasive procedure. A 
catheter is inserted into an artery, where a direct continuous intra-arterial measurement 
can be acquired. However, as intra-arterial catheter ABP measures require medical 
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expertise and often incur side effects such as pain, arterial damage, infection, and/or 
edema (48, 88), the technique is not practical in most settings. As a consequence, 
numerous indirect ABP measurement techniques have been developed and validated, 
including: ausculatory sphygmomanometry, osciollometry, and arterial tonometry. 
Ausculatory Sphygmomanometry 
The gold standard indirect method of measuring ABP involves the use of a 
sphygmomanometer. In this method, an inflatable cuff is placed around the upper arm, 
approximately 2-3 cm above the brachial artery (6). The cuff is inflated to a pressure 
greater than SBP, usually around 200 mmHg. This ensures cessation of blood flow 
through the artery. Air is slowly released from the cuff. A stethoscope placed over the 
brachial artery allows the health care professional to detect auditory changes in the 
artery. As the pressure in the cuff drops below SBP, around 120 mmHg in normotensive 
individuals, Korotkoff sounds can be heard (57). As the cuff deflates further and the 
pressure on the artery decreases, more blood is able to flow through the artery, and the 
sounds become increasingly louder until they disappear. The sound disappears when 
the pressure of the cuff falls below DBP, which represents complete flow of blood 
through the artery. This usually occurs around 80 mmHg in individuals with normal ABP 
(57). This method measures the pressure within the cuff, not the pressure of the artery 
itself and hence is an indirect method (99). This popular method, however, has inherent 
limitations, including observer error (particularly the reliance on the observer’s hearing), 
improper cuff size (which measures ABP inaccurately), and incorrect measurement 
techniques (which result in incorrect values for ABP) (82). This technique requires 
specialized training to limit the previously addressed limitations.  
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Osciollometry 
Osciollometry is another form of indirect ABP measurement and employs the 
same preparatory steps of placing a cuff around the upper arm, as described above. This 
method does not, however, rely on auditory feedback to determine ABP. Rather, it relies 
on oscillatory signals to estimate ABP (101). As pressure in the cuff decreases, 
oscillatory signals are collected by a microprocessor within the cuff.  Oscillatory signals 
begin above the value of SBP and cease below the value of DBP. The maximal 
oscillatory signal the device detects is equal to the mean ABP, which is an average of 
SBP and DBP (102). The microprocessor applies algorithms to this maximal signal to 
calculate SBP and DBP (101). This method only estimates SBP and DBP, and thus may 
result in inaccurate measurements of both values.  
 
Arterial Tonometry 
 
Arterial tonometry also measures ABP non-invasively. This technique allows for 
the continuous collection of the arterial pressure waveform, giving insight into the 
continuous fluctuations in ABP during a cardiac cycle (63). Instead of using a cuff to 
occlude blood flow in the brachial artery (as seen with the previous 2 methods), a 
pressure sensor is placed on a superficial artery (usually the radial artery (71), which lies 
on top of a bone. The principle of arterial tonometry is dependent upon the artery in 
question being compressible (35). In order to obtain an accurate pressure waveform, the 
pressure sensor must adequately flatten the artery. The Imbert-Fick law states the 
internal pressure of a completely elastic spherical body equals the force exerted on this 
body, divided by the flattened surface. This law allows for arterial tonometry to estimate 
ABP (63). Though this technique gives insight into continuous ABP, it does have some 
limitations: positioning of the device must be precise, motion artifacts can interfere with 
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the signal, and calibration of the device requires the use of an external measurement 
(63).  
1.1.4 Pathophysiology and Consequences of Hypertension and Recommendations 
for Treatment 
 HT is defined as a sustained elevation of resting ABP. ABP can be categorized 
as normal, pre-HT and HT. Normal values for SBP are ≤120 mmHg and ≤80 mmHg for 
DBP (15, 105). A person is classified as having pre-HT when their SBP ranges between 
120 -139 mmHg and/or their DBP ranges between 80-89 mmHg (15, 105). HT is 
classified as a SBP ≥140 mmHg and/or DBP ≥90 mmHg (15, 105). Stage 1 HT is defined 
as SBP between140 - 159 mmHg and/or DBP between 90 - 99 mmHg and Stage 2 HT 
as a SBP ≥160 mmHg and DBP ≥100 mmHg (15, 20). 
 HT can be of known or unknown causes. Essential (primary) HT encompasses 
95% of all cases of HT and the cause is unknown (20). In contrast, systemic (secondary) 
HT has a known cause, yet only accounts for a small percentage of all cases (20). As 
previously discussed, ABP is regulated through neural, local and hormonal control. A 
problem in one or more of these regulatory systems may contribute to the development 
and maintenance of HT. Essential HT tends to be genetically linked, where salt 
sensitivity, renin secretion, and obesity can be potential contributors to the 
pathophysiology of HT (20). This form of HT can be treated and/or prevented with 
lifestyle modifications (exercise and diet) and/or with pharmacological treatment (20). 
Systemic HT is unique in that it can be directly related to a specific physiological 
problem. For example, HT is often caused by problems occurring with the endocrine and 
renal systems and/or can be improved or even cured through medical therapy or surgery 
(20).  
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The pathophysiological manifestations and consequences of HT lead to pre-
mature death in treated and untreated individuals (20). The risk of developing CVD 
doubles for every incremental increase of 20 mmHg and 10 mmHg in SBP and DBP, 
respectively (14). HT is mostly associated with increased TPR and normal CO (20).  
HT can cause endothelial damage, which is believed to contribute to the 
development of vascular diseases, including atherosclerosis (20). Other outcomes of 
vascular damage include renal disease and stroke (20). In addition, chronic increases in 
TPR cause the heart to continually work harder to overcome this higher resistance and 
adequately perfuse the tissue. This can result in ventricular hypertrophy and dysfunction, 
and ultimately in overt heart failure (20).  
HT is associated with an increase in sympathetic outflow and decreased 
parasympathetic activity, including a reduced ability of the autonomic nervous system to 
modulate HR (HR variability; HRV) (111), all of which increase the risk of cardiac 
mortality (112).  
The primary prevention and treatment recommendations for HT include lifestyle 
modifications such as diet modification and exercise prescription, particularly in pre-HT 
individuals (15). Increased physical activity and dietary changes alone have been shown 
to reduce ABP and bring ABP to within the normal range (15). Other lifestyle 
modifications include maintaining a normal weight, decreasing dietary sodium intake, 
limiting alcohol intake, and following the Dietary Approaches to Stop Hypertension 
(DASH) eating plan (a diet containing a large amount of vegetables, fruit and low-fat 
dairy products) (15). In some individuals, following the DASH eating plan has been 
shown to be as effective as a single anti-HT medication (15). Therefore, lifestyle 
modification plays a vital role in the management and prevention of HT.  
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Pharmacotherapy is often prescribed if lifestyle modifications alone fail to 
decrease ABP to within the normal range (or ABP is morbidly elevated). There are many 
medications prescribed to treat HT and depending on the severity of the HT, more than 
one medication may be needed to adequately control ABP (15). The main classes of HT 
medications are: diuretics, angiotensin converting enzyme inhibitors (ACEIs), 
angiotensin receptor blockers (ARBs), β-blockers (BBs), and calcium channel blockers 
(CCBs) (15). 
Diuretics are recommended as the first type of pharmacological intervention, as 
they reduce cardiovascular complications associated with HT (15). The antihypertensive 
effects of diuretics are attributed to alterations in kidney function including: increasing the 
excretion of chlorine, sodium, potassium and bicarbonate ions in the urine, inhibiting the 
reuptake of sodium and chlorine ions by the kidneys, and decreasing uric acid and 
calcium excretion in the urine (20).  
ACEIs are effective in lowering ABP by preventing the conversion of angiotensin I 
to angiotensin II, which as previously described, is a potent vasoconstrictor (20). 
Reduction of circulating angiotensin II decreases vasoconstriction, which in turn reduces 
TPR and therefore, ABP. Individuals with diabetes are usually prescribed ACEI 
medications to protect their kidneys, as diuretics interfere with the normal functioning of 
the kidneys (20).  
ARBs evoke similar outcomes to ACEIs because they block angiotensin II from 
binding to its receptors (20). ARBs inhibit aldosterone secretion and the vasoconstrictive 
effects of angiotensin II (20).  Inhibition of aldosterone decreases blood volume, while 
decreasing vasoconstriction decreases TPR. Both of these outcomes result in TPR 
reductions.  
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BBs are another type of medication prescribed to lower ABP. These medications 
compete with epinephrine for the binding site on β-receptors (20). When BBs bind, they 
prevent epinephrine from stimulating the sinoatrial node to increase HR. Ultimately they 
decrease the force of cardiac contractility and HR, which result in a reduction of ABP 
(20).  
The most common class of CCBs used to treat HT are collectively named 
dihydropyridine CCBs (20). These types of CCBs act on the smooth muscles in the 
vasculature. They induce vasodilation by inhibiting the calcium influx into smooth muscle 
that causes vasoconstriction (20). The antihypertensive effect of this medication is a 
result of decreased TPR, and thus decreased ABP (20). A potential side effect of these 
medications is an increased in HR due to the rapid vasodilation of the vasculature (20). 
To avoid such complications, long-acting agents are preferred, as they result in gradual 
vascular changes, and prevent the rapid activation of the SNS (20).     
Recent evidence suggests that although chronic pharmacotherapy can reduce 
ABP to within the normal range, individuals still exhibit high levels of sympathetic outflow 
(28), despite this adequate ABP control. This high level of sympathetic outflow may 
explain the high rates of morbidity and mortality in individuals medicated for HT (28). 
In 2007, it was estimated that Canadians spent over $26 billion dollars on 
pharmaceuticals (10), with 20% of this spending accounting for hypertensive medications 
(77). While medication is effective in the treatment of HT, mortality rates in the HT 
population remain high. Furthermore, pharmacotherapy is effective in less than 50% of 
treated patients (74), leaving many unanswered questions surrounding the effectiveness 
of pharmacotherapy. 
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1.2 Exercise and Hypertension  
Exercise effects acute and chronic ABP regulation. As described in the previous 
section, physical activity can reduce chronic resting ABP, while the acute alterations in 
ABP occur to maintain muscle perfusion and activity. Exercise plays a large role in the 
prevention and management of HT, as previously discussed (20). The American College 
of Sports Medicine (ACSM) recommends aerobic exercise 3 to 7 times per week for 30 
to 60 minutes at an intensity of 30 (for sedentary individuals) to 85% (for regular vigorous 
exercising individuals) of an individual’s oxygen reserve to elicit the health benefits 
associated with exercise training (2). Resistance exercise is recommended as a 
supplement to this aerobic activity (2). The ACSM recommends resistance exercise be 
performed 2 to 3 times per week, where one set of 10-15 repetitions are performed for 
each of the major muscle groups (20).  Currently, there are no ACSM-endorsed 
recommendations for chronic isometric exercise training. 
1.2.1 Effects of Acute Exercise on Arterial Blood Pressure 
Aerobic Exercise 
Aerobic exercise (walking, running, swimming, cycling) involves the rhythmic 
contraction of muscles for a sustained period of time. At the onset of aerobic exercise 
SBP increases linearly, and during high intensity exercise, can reach values of > 200 
mmHg (54, 65). This increase in SBP is due to an increase in HR, CO, and blood flow to 
insure adequate perfusion of the active muscle (55). The pressor reflex (efferent muscle 
signals which causes constriction of the arterioles) also contributes to the rise in ABP. 
Active muscles respond to this increase in SBP through vasodilation, helping offset the 
rise in ABP (53). This results in a decrease in TPR, to levels less than at rest (53). As 
such, SBP does not remain high for the duration of the exercise, and generally 
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normalizes around 140-160 mmHg (65). As a result of TPR reductions, DBP changes 
minimally with aerobic exercise (65).  
Resistance Exercise 
Resistance exercise involves both static and dynamic exercise. During the static 
portions of the exercise, SBP/DBP have been shown to increase to values above 
400/200 mmHg (20). Resistance exercise affects many cardiovascular parameters 
including HR, SV, (thus CO) and blood flow (64). As with aerobic exercise, these 
parameters change depending on the intensity of the exercise. 
 During the concentric/eccentric portion of the exercise, blood flow to the 
contracting muscle is occluded, due to the mechanical compression of the vasculature 
(64). This occlusion causes the ANS to stimulate the SNS to increase CO, which results 
in an increase of ABP (64). Other contributors to the increase in ABP include the pressor 
reflex and the Valsalva maneuver (breath holds and/or forced exhalations against a 
closed airway). The Valsalva maneuver causes an increase in intrathoracic pressure, 
which results in an increase in ABP (58). The magnitude of ABP increase is directly 
related to the size of the contracting muscle, thus larger muscle masses induce larger 
changes in ABP (65).   
  
Isometric Exercise 
 Acute bouts of isometric exercise (sustained voluntary contraction of a muscle) 
have a unique effect on the cardiovascular system. At the onset of isometric exercise, 
increased HR, CO and sympathetic outflow are responsible for the initial increases in 
SBP and DBP (50, 62).  
Isometric muscle contraction results in occlusion of blood flow to the working 
muscle, as a result of the compression of the vasculature (62, 64). This induces the 
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pressor reflex, which increases sympathetic nervous activity, resulting in an increase in 
HR and CO, to ensure adequate blood flow to the contracting muscle (62). If the 
Valsalva maneuver is executed, ABP will further increase, due to the increase in 
intrathoracic pressure (58).     
As muscle force increases, the intensity of the exercise also increases, resulting 
in higher levels of ABP (53). The increase in ABP, however, is greater than the ABP 
needed to meet the metabolic demands of the working muscle by ensuring adequate 
muscle perfusion (53). Both increasing the size of the muscle mass performing the 
isometric exercise, and increasing exercise duration, influence ABP directly (53). With 
isometric exercise, however, ABP never reaches a steady state, but continues to 
increase (53).  
1.2.2 Post-Exercise Hypotension 
 Post-exercise hypotension (PEH) is a unique phenomenon characterized by a 
sustained reduction in resting ABP after an acute bout of exercise (85). PEH can be 
observed for up to 22 hours following an exercise bout (89). This event is most 
pronounced in individuals with HT (59). The average short-term PEH reductions in 
resting SBP and DBP are ~15 mmHg and ~4 mmHg, respectively (89).  
PEH has predominantly been investigated following bouts of aerobic exercise 
(59). Although there is evidence to suggest that resistance exercise elicits a PEH 
response; this finding is somewhat equivocal and not without controversy (23, 59) For 
example, some studies have shown a prolonged reduction in SBP, but no prolonged 
reduction in DBP (63, 64). A study conducted by O’Connor and colleagues (1993) found 
no prolonged reduction in ABP following resistance exercise. It is thought that the 
observed reductions in ABP post-resistance exercise may simply be due to the 
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reperfusion of blood to the working muscles that were previously occluded during muscle 
contraction (59). As PEH is described as a prolonged event and as such, some feel that 
should not be confused with these described reductions in ABP immediately following 
resistance exercise (59).  
 Consensus in the literature suggests that the mechanisms responsible for PEH 
acute bouts of aerobic exercise are decreased vascular resistance and a decrease in 
sympathetic nerve activity (17, 26, 36, 44, 59, 85). As previously noted, ABP is the 
product of CO and TPR. Therefore, if a decrease in sympathetic nerve activity occurs, 
there will also be a decrease in TPR and CO (including HR and SV). It could possibly be 
the decrease in sympathetic nerve activity that is responsible for the decrease in 
vascular resistance, which would allude to decreased sympathetic nerve activity being 
responsible for PEH. The effects of isometric exercise on PEH are unknown. 
1.2.3 Effects of Exercise Training on Arterial Blood Pressure 
Aerobic Exercise Training 
 A number of meta-analyses collectively affirm that aerobic exercise training, 
using a variety of exercise modalities (walking, running, cycling), frequencies (1 to 7 
days/week), durations (30-60 minutes) and intensities (30 to 90% maximum oxygen 
consumption), reduces resting ABP in both HT and normotensive individuals (89). 
Participants in these studies were between the ages of 18 to 79 years, demonstrating the 
effectiveness of aerobic training in reducing ABP throughout the lifespan (89).   
Overall, normotensive individuals showed average reductions of 2.6 mmHg and 
1.8 mmHg for SBP and DBP, respectively, while HT individuals exhibited larger average 
reductions in ABP, with SBP decreasing by ~7.4 mmHg and DBP decreasing by ~5.8 
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mmHg following training (89). The observed differences in total SBP and DBP reductions 
are most likely the result of initial differences in ABP values.   
 The specific mechanisms by which aerobic training alters ABP remains elusive, 
however, it is thought that an alteration in TPR, rather than CO, is responsible for this 
change (89). Vascular changes (e.g., increased endothelial-dependent mediated 
vasodilation), structural changes (e.g., increased cross-sectional area of resistance 
vessels), and functional changes (e.g., norepinephrine receptor desensitization and 
increased NO availability and release) are all likely candidates for aerobic training 
adaptations (89). Neural modifications (decreased sympathetic nerve activity) and 
genetics may also play a role in aerobic training adaptation (89). 
Resistance Exercise Training 
 A meta-analysis completed by Kelley and Kelley (2000), analyzed resistance-
training data from 11 randomized control trials. They found only small overall reductions 
in ABP, with a 2 - 4 mmHg reduction in SBP and a 3 - 4 mmHg reduction in DBP. 
However, similar reductions have shown to decrease the risk of stroke and coronary 
heart disease (47). Resistance training also improves ABP spikes during exercise (64). 
As an individual becomes more advanced/trained in resistance exercise, they exhibit 
smaller increases in both SBP and DBP (64).  
 The mechanisms thought responsible for these ABP reductions following 
resistance training are similar to those seen with aerobic training (89), such that 
vascular, structural, functional and neural adaptations may be responsible for altering 
ABP through inducing changes in TPR (89). 
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Isometric Exercise Training 
Early studies involving isometric exercise training, examined whole-body 
isometric exercise and the effects of training on resting ABP. Kiveloff and colleagues 
(1971) observed in unmedicated hypertensives, following 5 to 8 weeks of isometric 
training, 3 times per week, decreases in SBP of 4 - 28 mmHg and DBP of 2 - 14 mmHg 
(49).  
Later studies investigated the benefits of a simpler isometric training protocol: 
isometric handgrip (IHG) exercise (118). For example, 8-weeks of IHG training in 
normotensive individuals resulted in reductions in resting SBP of 12 mmHg and DBP of 
14 mmHg. This protocol involved 4 isometric contractions of the dominant arm for 2 
minutes, separated by 3 minutes of rest, at 30% maximum voluntary contraction (MVC), 
performed 3 times per week (85). Ray and colleagues (2000) further supported the 
effectiveness of IHG training in reducing ABP in normotensive individuals. Using a 
similar exercise protocol (4 isometric contractions separated by 5 minutes of rest, 4 times 
per week for 5 weeks) they found significant reductions in resting mean ABP (MAP) of 4 
mmHg and DBP of 5 mmHg. Although resting SBP decreased by approximately 3 
mmHg, this did not yield statistical significance (85).  In 2007, a study examining 
normotensive individuals and the effects of an 8-week unilateral IHG protocol (consisting 
of 4, 30% MVC contractions, sustained for 2 minutes with the non-dominant hand, with 4 
minutes of rest between contractions) found similar ABP reductions. Investigators 
reported a 4.9 mmHg reduction in SBP with no significant differences in DBP (66).  The 
clinical impact of IHG training was explored by Taylor and colleagues (2003) who 
investigated the effects of 10 weeks of IHG training, performed 3 times per week 
(consisting of 4, 30% MVC contractions, sustained for 2-minutes with alternate hands, 
each contraction separated by 1 minute of rest) in HT individuals. The findings of this 
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study support the benefits of IHG training, showing resting SBP and DBP to decrease by 
19 mmHg and 7 mmHg, respectively (111). 
 McGowan and colleagues (2006) examined the effects of 8 weeks of bilateral 
(consisting of 4, 30% MVC contractions, sustained for 2 minutes with alternate hands, 
with 1 minute of rest between contractions) and unilateral (consisting of 4, 30% MVC 
contractions, sustained for 2 minutes with the non-dominant hand, with 4 minutes of rest 
between contractions) IHG training protocols in medicated hypertensives. Subjects 
completed IHG training 3 times per week for a total of 8 weeks. No changes in DBP were 
found, however, the bilateral training reduced SBP by 15.4 mmHg and the unilateral 
protocol reduced SBP by 9.2 mmHg. This study demonstrated both bilateral and 
unilateral IHG training programs are able to reduce SBP. 
 In 2007, a multilevel analysis was performed to amalgamate 3 previous IHG 
training studies performed at McMaster University (75). The analysis population involved 
medicated hypertensives that had performed either a bilateral or unilateral (as described 
in the previous paragraph) training program for 8 weeks (3 times per week).  The results 
of this multilevel analysis showed combined reductions of 5.7 mmHg and 3.0 mmHg for 
SBP and DBP, respectively (75).  
 Most recently, Millar and colleagues examined the effects of IHG training in 
normotensive individuals (72). They used an 8-week, 3 times per week, bilateral training 
protocol (as described earlier). This study showed reductions in both SBP and DBP of 10 
mmHg and 3 mmHg, respectively. This study further supports the validity that IHG 
training in an effective exercise to reduce ABP.  
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1.3. Heart Rate Variability 
Autonomic modulation of HR (HR variability; HRV) can be estimated by 
determining beat-to-beat variations in HR in the time or frequency domain.  
Time domain HRV analysis  
Common variables used for time domain analysis include, among others, the 
standard deviation of all normal R-R intervals (see Figure 2) within an established time 
interval, the standard deviation of beat-to-beat pulse interval variations, and the number 
of differences of successive R-R intervals (Figure 3) > 50 msec/total number of R-R 
intervals.  
Frequency domain HRV analysis  
Spectral analysis is a noninvansive frequency domain method used to estimate 
contributions of the PNS and SNS to short- and long-term oscillations in HR. The most 
common algorithms employed for this purpose include fast Fourier transformation (FFT), 
autoregressive analysis (AR) and coarse-grain spectral analysis (CGSA). 
 
 
 
 
Figure 2- ECG signal- Depicting the R-R interval used to assess HRV (78). 
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Figure 3: Consecutive R-R Intervals- displays the beat number vs. length of heart beat 
(R-R) (adapted from 1). 
 
1.3.1 Assessment of Heart Rate Variability 
Fast Fourier Transformation 
Fast Fourier Transformation (FFT) is a unique form of frequency domain analysis 
in that the R-R signal is not filtered prior to processing (5, 87).  Once the ECG signal is 
obtained, the signal is subdivided into seven equal segments. Each of the segments is 
halfway overlapped by adjacent signal segments (37). Signals are often periodic in 
nature, which leads to the breakdown of the signal into sinusoidal waves (37). Signals 
are often accompanied by spectral noise that must be eliminated to provide a more 
accurate analysis. Using the correct parameters is essential because if they are set too 
small, they do not provide a good representation of the original signal. Alternatively, if the 
parameters are set too high, the signal is accompanied by a great amount of noise and 
inaccuracies (92). The signal parameters are determined by applying linear regression 
analysis to the entire signal, followed by the subtraction of the linear trend from each of 
the individual 7 segments (3, 37, 51). In order to minimize spectral leakage (loss of data) 
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within a finite observation and smooth the spectral signal, windowing functions (spectral 
analysis; FFT) must be applied (37). The application of a FFT allows the signal to be 
easily interpreted and evaluated using a graphical representation of the data (5, 37; See 
Figure 4 (1)). The graphical product of the FFT defines the frequency bands: very low 
frequency (VLF), low frequency (LF), and high frequency (HF) (3). The LF component 
provides insight into the sympathetic modulation of HR, while the HF component 
provides insight into the parasympathetic modulation of HR (5, 111). The VLF 
component corresponds to non-harmonic noise within the spectrum (111). The ratio of 
LF: HF can be examined to give insight into the sympathovagal influences contributing to 
the alterations in HR by the autonomic nervous system (111).  
 
 
Figure 4: FFT spectral analysis- Depicts the VLF, LF and HF peaks of the signal 
(adapted from (1)). 
 
Autoregressive Modeling  
 Autoregression (AR) is a model used to analyze a time series of data (in this 
case, R-R intervals) to determine the number, center frequency and powers of the 
oscillatory components (52, 76, 87, 90). Similar to FFT, this method of analysis requires 
a set of parameters (model order) to establish the frequency spectrum and there are 
many techniques available (e.g. Akaike Information Criterion) to determine the correct 
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parameters (92). Once the parameters have been selected, Burg’s algorithm is used to 
determine the coefficients for AR, which enables power spectrum acquisition (92; See 
Figure 5). Like FFT, AR defines the following peaks: very low frequency (VLF), low 
frequency (LF), and high frequency (HF), and thus describes the bands of the power 
spectrum.   
 
Figure 5: AR spectral analysis- Depicts the VLF, LF, and HF bands of the spectrum 
(adapted from 1). 
 
In comparison to FFT, AR models create smoother power spectra with better 
frequency resolution from shorter segments of data, only requiring one or more 
sinusoidal waves (92). Though FFT and AR models produce similar findings, in 
individuals with high HRV, AR tends to overestimate LF and underestimate HF powers 
compared to the FFT model of analysis (16).  
Coarse Graining Spectral Analysis 
Coarse Graining Spectral Analysis (CGSA) allows for more accurate quantitative 
analysis by acquiring clearer peaks in the LF and HF components (119). This is 
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accomplished by first dividing the total spectral power (TP) into non-harmonic (fractal) 
and harmonic (oscillatory) components (81). This type of analysis is particularly useful in 
subjects who have reduced harmonic spectral power and preserved non-harmonic power 
(i.e., heart failure and hypertension) (81). After the harmonic component is determined, 
this component is integrated across the LF and HF ranges. The HF integrated range can 
then be normalized to the TP, determined by dividing HF by TP. The LF: HF ratio gives 
insight into the autonomic balance in the regulation of HR (119). 
1.3.2 Reduced Heart Rate Variability 
 Reduced HRV increases the risk of cardiac mortality (112). The weight of 
evidence suggests that individuals with HT have reduced HRV in the time domain 
compared to normotensive subjects (104). There is also data to suggest that HF power 
(vagal tone) is reduced (1, 87) and the LF component of the power spectra is augmented 
in individuals with HT (32, 87) although this latter finding is equivocal. The discrepant 
findings in the LF power spectra may, however, be accounted for by methodological 
differences. Reduced HRV is also associated with a number of other CVD risk factors 
including aging, smoking, and physical inactivity (21), and diminished HF power and 
increased LF power are prevalent in the CVD population as a whole (21).  
1.3.3 Treatment of Reduced Heart Rate Variability 
As reduced HRV is a known risk for increased cardiac mortality, the benefits of 
improving HRV have been speculated upon, however, it is unknown whether improving 
HRV decreases the risk of cardiac mortality (1). Pharmacotherapy has been investigated 
as a treatment option for reduced HRV.  
BBs have been shown to increase HRV in patients after a myocardial infarction 
(1). Specifically, the rise of the LF component in the morning hours (due to sleep to wake 
transition; increase in sympathetic tone) was blunted (1). HRV has been shown to 
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increase with a low-dose of muscarinic receptor blockers (Scopolamine, atropine) (1). In 
both post-myocardial infarction patients and those with chronic heart failure, 
Scopolamine was shown to significantly increase HRV. Specifically, this medication was 
shown to increase vagal tone, which could also be observed, as individuals had a 
decrease in heart rate (1). The large scale and long-term effects of these medications 
require further investigation (1).  
Exercise training, as well as, dietary changes and maintenance of normal weight 
are commonly employed interventions aimed at improving autonomic modulation of HR 
(15). 
1.4 Exercise and Heart Rate Variability 
1.4.1 Effects of Acute Exercise on Heart Rate Variability 
 The effects of acute exercise on post-exercise HRV have been under-
investigated, however, the available evidence supports beneficial changes in HR 
modulation following a bout of aerobic exercise. For example, Javorka and colleagues 
(2002) observed increased HF power, decreased LF power and an improved LF/HF ratio 
following an acute bout of bench step climbs for 12 minutes in healthy normotensive 
males (43). The authors attributed these findings to an increase in parasympathetic tone 
upon the cessation of exercise. Raczak et al. (2005) investigated the effects of 30 
minutes of constant treadmill exercise on post-exercise HRV. Upon cessation of the 
exercise, HRV increased (all indices of parasympathetic activity increased) (95).   
 These results are somewhat equivocal however, as contrary to the findings of the 
previous 2 studies, other studies have shown decreases in HRV post-exercise. Healthy, 
normotensive, sedentary men were engaged in both interval (45 minutes) and steady 
state (time adjusted so participants produced the same amount of work as interval 
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exercise) cycling exercise (78). Both protocols decreased post-exercise HRV (TP, LF, 
HF; 78).  Masters athletes (men and women; regular cyclers) who engaged in 25 - 35 
minutes of incremental cycling until a lactate threshold of 4.5mmol was observed showed 
a post-exercise decrease in HRV (TP, VLF, LF and HF) compared to pre-exercise 
indices (9).  
 The evidence suggests the mode, intensity and duration of exercise play a role in 
post-exercise HRV, and it can be either improved or reduced after an acute bout of 
aerobic exercise. 
1.4.2 Effects of Exercise Training on Heart Rate Variability 
Aerobic Exercise 
 The effects of aerobic training on HRV have been thoroughly investigated (7, 12, 
29, 45, 108), and although the findings are somewhat inconclusive, they appear 
population dependent. Although there is data to suggest an improvement in HRV with 
aerobic training in patient populations and in older individuals, this has not consistently 
been demonstrated in young, healthy populations. For example, in a study examining the 
effects of 8-weeks of endurance-based (static cycling and calisthenics) cardiac 
rehabilitation on HRV in patients who had experienced a myocardial infarction (61), 
investigators noted improved HRV, (increase in HF power and decrease in LF power) in 
the exercise group compared to the non-exercising control group (61). These 
improvements persisted for 1 year following training, in contrast to the control group, who 
still experienced reduced HRV after the 1-year period (61).  Furthermore, Stein and 
colleagues (1999), revealed significant increases in HRV (increase in TP, LF and VLF) 
after a 12-month aerobic training program (3 month initial flexibility training, followed by 9 
months endurance exercise (walking, jogging, cycling and rowing), 5 days per week, 45-
60 minutes, 60 to 85% VO2max) in healthy older individuals. These changes may be 
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attributed to the population group, as older individuals have decreased HRV, or to the 
longer duration of training. A more recent investigation determined that, 8 weeks of 
aerobic training elicited marked increases in HRV (LF power increase (9%) and HF 
power increased (11%) in post-menopausal women (45) who performed treadmill and/or 
recumbent cycling (3-4 times per week, 120-165 minutes, at 50% VO2max)) (45).  
 In contrast, Boutcher and colleagues (1995) found healthy middle-aged 
individuals who underwent 24 aerobic training sessions (20-30 minutes 
walking/jogging/cycling, 3 times per week, at 60% HR range) to have no significant 
alterations in HRV. Similar findings were noted in healthy, young, middle-aged men 
following 3-months of aerobic training (40 minutes of walking and/or jogging, 3 times per 
week, 75 to 80% peak HR) (12). Again, no significant post-training changes in HRV were 
observed in this group (12). This lack of change in HRV may be attributed to the 
population being examined, as younger individuals have increased HRV compared to 
their older counterparts.  
Resistance Exercise 
 The effects of resistance training on HRV have been investigated to a lesser 
degree than aerobic training; however, the results continue to support increases in HRV 
with exercise in clinical and older populations. In an early study examining the effects of 
3 months of resistance training (circuit training, 3 times per week, at a moderate 
intensity) in persons with chronic heart failure (100), significant increases in HRV were 
observed (increase in HF power and decrease in LF power). More recently, the effects of 
16 weeks of resistance exercise (30 minutes circuit training, 8-12 repetitions, 50-80% of 
1 repetition maximum, 2 times per week) were examined in women with Fibromyalgia 
who had pre-training reductions in HRV (22). Investigators found increased HRV 
(increase in TP and HF power) after the training program.  
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Isometric Exercise 
Few studies have investigated the effects of isometric training on HRV. In 2003, 
Taylor and colleagues investigated the effects of 10 weeks of IHG training on HRV in 
hypertensive individuals (3 times per week, 4, 30% MVC contractions, sustained for 2-
minutes with alternate hands, separated by a 1 minutes rest period). This study further 
supports the benefits of exercise training on HRV in clinical populations, as the 
investigators observed improvements in HF power following the training period (111).  
1.5 Ambulatory Blood Pressure and the effects of Exercise Training 
Ambulatory ABP gives insight into the 24-hour fluctuations of ABP, and is 
reflective of activities of daily living. Although controversial, diagnostic clinical ABP 
measurements appear to inaccurately estimate resting ABP, and 40% of the time these 
readings are incorrect, as compared to 24-hour ABP measurements (38). Furthermore, 
ambulatory ABP is more efficacious in predicting CVD related events than clinical resting 
ABP measures (91). The benefits of ambulatory ABP monitoring have made this practice 
an increasingly popular tool in the clinical setting (91). 
The mean ambulatory values for ABP in normotensive individuals are 135 mmHg 
and 85 mmHg (91) for SBP and DBP, respectively, although ambulatory ABP in 
normotensive individuals do have diurnal rhythms. These diurnal rhythms can also be 
observed in many individuals with HT, however, the ABP mean values in this population 
are increased overall (91). Ambulatory blood pressure is highest during the morning 
hours (attributed to the change from a sleep to a waking state) and lowest (10 - 20% 
lower) during the sleeping hours (91). 
The effects of exercise training on ambulatory ABP have been underinvestigated. 
Van Hoof and colleagues (113) found healthy males who performed endurance exercise 
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for 4 months experienced reductions in daytime DBP by ~5 mmHg. Ambulatory ABP was 
shown to decrease by 4.8 mmHg and 7.5 mmHg for SBP and DBP, respectively, in mild 
and borderline HT individuals after 6 months of endurance training (106). Palatini and 
colleagues (86) also examined the role of exercise training in ABP. Unmedicated HT 
individuals (86) were divided into an exercise training group and a control group by self-
reported indices of exercise. If subjects reported to participate in aerobic sports, at least 
1 time per week, they were included in the training group, and those who did not partake 
in such activities, were assigned to the control group (86). Results showed similar SBP 
values between the training and non-training groups, however, the training group 
exhibited lower DBP (4 mmHg). The training group also had smaller differences in both 
day and night ambulatory ABP than the control group (86).     
A meta-analysis of 11 studies, conducted by Cornelissen and Fagard in 2005, 
examined the effects of ≥ 4 weeks of exercise training (walking, running, cycling) on 
ambulatory ABP (13). Daytime SBP and DBP decreased by 3.0 mmHg and 2.4 mmHg 
while nighttime ABP decreased 3.3 mmHg and 3.5 mmHg for SBP and DBP, 
respectively (13). This study reaffirmed the previous studies, showing endurance 
exercise can significantly decrease ambulatory ABP in both normotensive and 
hypertensive individuals.  
1.6 Summary of Background 
  CVD is the leading cause of death in Canada, with HT significantly contributing 
to the risk of its development. HT is a complex pathophysiological disease, which rarely 
can be attributed to a known cause. Individuals with HT have elevated resting and 
ambulatory ABP, experience PEH following many forms of exercise, and have reduced 
HRV.  
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The prevention and treatment of HT include lifestyle modifications and 
pharmacotherapy. Many individuals treated with pharmacotherapy remain above the 
normal ABP range, yet others remain unaffected. Lifestyle modifications, particularly 
exercise, have proven to be a successful means of lowering resting and ambulatory ABP 
and improving HRV. IHG training is a novel, non-time consuming, and simple form of 
exercise, shown, in individuals with and without HT, to markedly reduce resting ABP. 
The transfer of these effects to activities of daily living (i.e., ambulatory ABP), however, is 
currently unknown. Furthermore, individuals with HT have shown improvements in HRV 
with IHG training; however, the PEH and HRV response post-IHG bout remain unknown, 
as are the effects of IHG training on these responses.  
1.7 Thesis Objectives 
The objectives of this thesis project are 2-fold: 
1. To investigate the ABP (PEH) and HRV responses immediately following a bout of 
IHG in individuals medicated for hypertension, and to observe the effects of training on 
these responses, 
2. To replicate previous reductions in resting ABP and improvements in HRV, and 
observe the effects of training on 24-hour ambulatory ABP, 
1.8 Specific Hypotheses  
The substantive hypotheses are: 
1. HT individuals will experience PEH following an acute bout of IHG exercise 
accompanied by an increase in vagal modulation in HR, prior to training, and it is 
expected that these responses will be altered after 8 weeks of training.  
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2. Resting and ambulatory ABP will decrease with 8-weeks of bilateral IHG training, and 
resting HRV will improve with training. 
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CHAPTER 2: General Methodology 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
2.1 Overview  
 The general methodology chapter provides an overview of the methods used to 
study the effects of isometric handgrip exercise on post-exercise hypotension, 
ambulatory arterial blood pressure and heart rate variability in individuals 
medicated for hypertension. Although the data was collected in one large study, for the 
purposes and ease of knowledge translation and publication, the data has been 
separated, and will be presented as 2 manuscripts.  
The first, entitled: Acute effects of IHG exercise on arterial blood pressure 
and heart rate variability in medicated hypertensives and the influence of training, 
and described in detail in Chapter 3, was designed to examine two research questions: 
1) Does an acute bout of IHG cause sustained reductions in ABP and improvements in 
HRV (specifically improved vagal modulation of heart rate)? and, 2) Does 8-weeks of 
IHG training attenuate the acute ABP and HRV responses following a single bout of IHG 
exercise? In order to answer the proposed questions, 11 participants trained 3 times per 
week for 8-weeks, and 9 individuals served as non-trained ABP controls. Measures of 
pre-IHG ABP and HRV, and post-IHG ABPs and HRV were acquired for all participants 
at baseline, after 4 weeks of training or control ABP measures (mid-training; week 5), 
and following 8 weeks of training or control ABP measures (post-training; week 9). 
The second, entitled:  Effects of isometric handgrip training on resting and 
24-hour ambulatory arterial blood pressure and heart rate variability in individuals 
medicated for hypertension, and described in detail in Chapter 4, was designed to 
examine two research questions: 1) Does 8-weeks of IHG training reduce resting and 
ambulatory ABP in medicated hypertensives? and, 2) Does IHG training improve HRV in 
individuals medicated for hypertension? Eleven individuals trained 3 times per week for 
8-weeks, and 9 participants served as non-trained ABP controls. Measures of resting 
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and ambulatory ABP and HR were acquired for all participants at baseline, after 4 weeks 
of training or control ABP measures (mid-training; week 5), and following 8 weeks of 
training or control ABP measures (post-training; week 9). 
 The general methodology chapter includes descriptions of the study participants, 
the large-scale study design, the IHG training protocol, and the testing methodologies. 
These include pre- and post- ABPs and HRV measures, resting ABP, and ambulatory 
ABP.  
 Comprehensive details regarding the study participants, data collection and 
analyses protocols, and statistical analyses for the above-noted manuscripts are 
described in each of Chapters 3 and 4. 
2.1.1 Study design 
 The University of Windsor Research Ethics Board approved this randomized 
controlled study (REB# 09-060; Appendix D). After inquiring about the study, participants 
were required to meet with study investigators (Physical Activity and Cardiovascular 
Research (PACR) laboratory, Room #240, Human Kinetics Building, University of 
Windsor, Windsor, ON, Canada) for an informational meeting and to sign a letter of 
information (Appendix E), an informed letter of consent (Appendix F) and a medical 
questionnaire (Appendix G). Upon review of the medical questionnaire and 
establishment of eligibility, participants returned to the PACR laboratory (Room #240, 
Human Kinetics Building, University of Windsor, Windsor, ON, Canada) to undergo 
familiarization of all testing procedures.  
 Following habituation, participants were randomized to the IHG training group or 
the non-exercising control group. In order to randomize participants into groups, 
GraphPad software was employed to assign participants to the various groups 
(GraphPad Prism 5, GraphPad Software Inc, La Jolla, CA, USA). Each participant, on 
 49 
entrance into the study, was sequentially assigned a number, thus being assigned to a 
group depending on the assignment of the software. Participants assigned to the IHG 
training group were instructed on the proper IHG exercise techniques. 
 After participants were assigned to their experimental group, they underwent 2 
days of baseline testing procedures (pre-training), which were repeated by all 
participants after 4 weeks of IHG training or ABP monitoring (week 5; mid-training) and 
after 8 weeks of IHG training or ABP monitoring (post-training).   
2.2 Isometric Handgrip Training 
2.2.1 General Description 
 The IHG device (ZonaPLUS, Zona HEALTH, Boise, ID, USA; see Figure 6) is a 
computerized handgrip dynamometer programmed to execute 4 sets of 2-minute 
isometric contractions (using alternate hands) at 30% maximal voluntary contraction 
(MVC; determined at the onset of each exercise session, on each limb, via electronic 
linear load cells contained within each IHG device), each separated by 1-minute rest 
intervals (8,10).  
 
Figure 6- Zona handgrip dynamometer 
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 Participants trained in the seated position with their training arm (which alternated 
with each contraction) placed on a table directly in front of them. Their lower arm rested 
on the table at a 90° angle from the upper arm.  See figure 7 for a picture of the IHG 
training position.   
 
Figure 7- IHG training position 
2.2.2 Exercise Training Protocol 
  Participants assigned to the IHG training group trained 3 times per week, for a 
total of 8 weeks. Two training sessions per week took place under the direct supervision 
of an exercise trainer, and the third session was conducted in the participants’ home. 
Participants were provided with detailed instructions to ensure proper at home training, 
and were instructed to record their exercise, nutritional, and medication data in exercise 
log books to ensure consistency throughout the intervention period (Appendix H). 
 Each training session took approximately 30 minutes. Prior to the on-site training 
session, participants had their ABP measured using brachial arterial osciollometry 
(Dinamap ProCare 100, Critikon, Tampa, FL, USA). Participants then performed a bout 
of IHG exercise.  
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ABP Control Group 
 Participants randomized to the non-exercising control group visited the laboratory 
2 times per week to have their ABP measured. In addition, this enabled acute monitoring 
of exercise, nutritional, and medication status throughout the study. 
2.3 Outcome Measures 
2.3.1 Testing Protocol Procedures 
To minimize the influence of external factors on the cardiovascular measures, 
participants were asked to refrain from the consumption of alcohol and exercise for 24 
hours prior to each testing session, and to avoid caffeine consumption for 12 hours prior 
(10). All testing was conducted in the morning, in a quiet, temperature-controlled room, 
following a light breakfast. On both testing days, all participants were asked to void their 
bladder prior to the testing session to minimize the effects of bladder distension on blood 
pressure (4). 
2.3.2 Brachial Artery Osciollometry  
Brachial artery osciollometry was used to measure pre- and post-IHG ABP and 
HR (Chapter 3: Acute effects of IHG exercise on arterial blood pressure and heart rate 
variability in medicated hypertensives and the influence of training), and for resting ABP 
and HR and 24-hour ambulatory ABP (Chapter 4: Effects of isometric handgrip training 
on resting and 24-hour ambulatory arterial blood pressure and heart rate variability in 
individuals medicated for hypertension).  
Pre-IHG, post-IHG ABP and HR (immediately following, 1 hour and 2 hours post-
IHG), and resting ABP and HR were measured (Dinamap ProCare 100, Critikon, Tampa, 
FL, USA) after 10 minutes of seated rest, whereby participants were instructed to keep 
their feet flat on the floor (12). Their right arm was adjusted adjacent to the body at heart 
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level and an ABP cuff (23 – 33 cm) was placed around the upper arm to acquire ABP. 
Figure 8 shows the resting ABP upper-body and arm position.   
 
Figure 8- Resting ABP body position 
 
 Three hour to 22 hour post-IHG ABPs and HRs were measured using an ambulatory 
osciollometric ABP monitoring device (Spacelabs 90207 Ambulatory Blood Pressure 
Monitor, SpaceLabs Inc., Redmond, WA, USA; Chapter 3:  Acute and chronic effects of 
IHG exercise and training on post-exercise hypotension and heart rate variability in 
medicated hypertensives). Specifically, the upper right arm was secured with the ABP 
cuff (cuff size: 24 - 32 cm) and the square monitor was attached with a belt to the 
participant’s waist (see Figure 8 for a depiction of monitor placement). This enabled an 
additional 20 hours of ABP and HR to be monitored post-IHG exercise (3 to 22 hours 
post-IHG), for a comprehensive total of 22 hours post-IHG (11).  Finally, 24-hour 
ambulatory ABP and HR were assessed via the same oscillometric ambulatory ABP 
device (Chapter 4:  Effects of isometric handgrip training on resting and 24-hour 
ambulatory arterial blood pressure and heart rate variability in individuals medicated for 
hypertension). 
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Figure 9- Spacelabs ambulatory ABP cuff: Depicts the placement of the ambulatory 
ABP cuff on the participant’s right arm. The square monitor was secured on the 
participant’s belt loop.  
2.3.3 Electorcardiography 
Electrocardiography was used to monitor continuous beat-to-beat heart rate (HR) 
(Chapter 3: Acute effects of IHG exercise on arterial blood pressure and heart rate 
variability in medicated hypertensives and the influence of training). Prior to and following 
an acute bout of IHG exercise, HR was measured pre-IHG using standard 
electrocardiography (ECG), whereby a set of 3 electrodes was placed on the 
participants’ chest. To minimize lead placement errors, the same investigator performed 
the ECG setup at all testing sessions (3). All R-R interval HR data was recorded for 10 
minutes for later analysis of HRV.  
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2.4 Data Analysis 
2.4.1 Resting ABP and HR 
For resting ABP, pre-IHG and post-IHG (immediately, 1-hour and 2 hours post-
IHG) ABP and HR measures (Dinamap ProCare 100, Critikon, Tampa, FL, USA), 4 ABP 
and HR values were acquired by the same trained investigator following a 10-minute rest 
period, where each measure was separated by 2 minutes (14). The latter 3 measures 
were averaged and used in the final analysis.  
2.4.2 Ambulatory ABP and HR 
 Twenty hour ambulatory and post-IHG ABP and HR (3 hours to 22 hours post-
IHG; Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, 
WA, USA) were recorded 2 times per hour during daytime hours (6 am – 10 pm), and 1 
time per hour during nighttime hours (10 pm – 6 am) (7). Values were averaged during 
each hour, time period (daytime and nighttime), and during the entire 24-hour ambulatory 
period. 
2.4.3 Pre- and Post-IHG HR for HRV analysis 
As mentioned above in the section entitled: Electrocardiography, 10 minutes of R-
R interval HR data was recorded prior to and following a bout of IHG for later analysis of 
pre- and post-IHG HRV.  HR signal output was sampled at a frequency of 1,000 Hz. The 
analogue signals were converted to digital signals using a data acquisition board 
(PowerLab 8/30, ADInstruments Inc., Colorado Springs, CO, USA) for off-line beat-to-
beat analysis. Ensemble averages of 256 beat sequences were taken from a minimum 
time series of 400 beats (9). Ectopic beats were edited and replaced via linear 
interpolation from adjacent cardiac cycles (9). Only tracings with ≤5% ectopy-corrected 
beats were accepted for analysis (9), therefore 2 of the 20 participants were excluded 
from the HRV analysis. To determine HRV, R-R (i.e. pulse) intervals obtained during the 
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baseline 10-minute data acquisition period were submitted to coarse graining spectral 
analysis (CGSA)(9,15). 
CGSA is a non-invasive frequency domain analysis method used to estimate 
contributions of the PNS and SNS to short- and long-term oscillations in HR.  The output 
of the CGSA analysis defines the following frequency bands: very low frequency (VLF), 
low frequency (LF), and high frequency (HF) (2). The VLF component corresponds to 
non-harmonic noise within the spectrum (13). The LF component provides insight into 
sympathetic modulation of HR, while the HF component provides insight into vagal HR 
modulation (1, 13). The ratio of LF:HF, although controversial, is said to provide insight 
into the sympathovagal influences contributing to the alterations in HR by the autonomic 
nervous system (13).  The ratio of HF:TP provides information regarding the 
parasympathetic modulation of HR (9). CGSA allows for more accurate quantitative 
analysis of HRV by acquiring clearer peaks in the LF and HF components of the power 
spectrum (15). This type of analysis is particularly useful in clinical populations who have 
reduced harmonic spectral power and preserved non-harmonic power, such as those 
with hypertension (5).  
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Introduction:  
Hypertension (HT), a disease characterized by sustained elevations in resting 
arterial blood pressure (ABP) and autonomic dysfunction (40), afflicts approximately 972 
million people worldwide (11). Considerable attention has been given to the beneficial 
effects of aerobic and resistance exercise on reducing resting ABP in individuals with HT 
(7,12,15,35,36,41). Meta-analyses of aerobic training studies suggest average 
reductions of ~7 and ~6 mmHg in SBP and DBP, respectively (36), and average 
reductions of ~3 and ~4 mmHg in SBP and DBP, respectively, following resistance-
training interventions (18) in this population. Based on the weight of the evidence, 
current guidelines put forth by the American College of Sports Medicine for individuals 
with hypertension recommend aerobic exercise (moderate-intensity for 30 - 60minutes) 
most days of the week and resistance exercise (1 set of 8 to 12 repetitions for the major 
muscle groups) 2 - 3 days per week (1). The mechanisms thought responsible for 
training-induced hypotension include vascular, structural, functional and neural changes 
that alter ABP by primarily inducing changes in total peripheral resistance (TPR; 36). 
 With respect to acute exercise, post-exercise hypotension (PEH), a phenomenon 
defined by a prolonged reduction in ABP following an acute bout of exercise, has been 
observed for up to 22 hours post-exercise and is most pronounced in those with 
hypertension (36). These acute exercise-induced changes in ABP not only offer the 
potential benefit of short-term ABP control by providing temporary reductions in daily 
ABP, but also offer insight into the pathophysiology of HT and the subsequent response 
to different modes of exercise. 
PEH has predominantly been investigated following bouts of aerobic exercise, 
and has been observed following 10 to 170 minutes of a variety of aerobic exercises 
(walking, running, cycling; 19). The average short-term PEH reductions in resting ABP 
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are ~10/~7 mmHg, in SBP and DBP respectively (20). Although there is evidence to 
suggest that resistance exercise elicits a PEH response, this finding is not without 
controversy (8,20). For example, some studies have shown a prolonged (>2hrs) 
reduction in SBP, but no prolonged reduction in DBP (21,24), while others have found no 
post-exercise ABP alterations (33). Furthermore, some believe that the observed 
reductions in ABP post-resistance exercise may simply be due to the reperfusion of 
blood to the working muscles that were previously occluded during muscle contraction 
(20). Consensus in the literature suggests that the mechanisms responsible for PEH are 
likely multi-faceted, and include a reduction in vascular resistance and/or decreases in 
sympathetic nerve activity (5,9,12,17,20,34).  
A more novel form of exercise training, isometric handgrip (IHG) training (four, 2-
minute sustained contractions at 30% maximal voluntary contraction (MVC), separated 
by a timed rest period, 3x/week for 8 - 10 weeks) is a less time consuming exercise 
repeatedly shown to reduce resting ABP (19,26,27,38). Recently, a meta-analysis 
supported bilateral IHG training as an efficacious way to attain significant exercise-
induced ABP reductions (~5 and ~3 mmHg in SBP and DBP, respectively) in non-clinical 
(young healthy individuals) and clinical populations (hypertension) (19). Although the 
acute effects of IHG on post-IHG ABP in individuals with hypertension have not been 
thoroughly investigated, in a population of 18 older (70 ± 5 years) healthy adults (9 
females), a post-IHG reduction of ~3 mmHg in SBP was observed 5 minutes post-IHG 
(30).  
In addition to the ABP-specific effects of acute and/or chronic aerobic, resistance 
and isometric exercise, the broader scale effects of exercise on autonomic function have 
been examined. Spectral analysis of heart rate variability (HRV) is a popular non-
invasive tool used to assess autonomic function, and provides insight into the autonomic 
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modulation of heart rate (HR) (40).  HRV assessment has been widely employed under 
resting conditions, and following acute and chronic exercise, in both non-clinical and 
clinical populations, including those hypertensive individuals with compromised nervous 
systems. Coarse graining spectral analysis (CGSA) is a non-invasive frequency domain 
analysis method used to estimate contributions of the parasympathetic and sympathetic 
nervous systems to short- and long-term oscillations in HR. CGSA yields two 
components, harmonic and non-harmonic components, with the latter representing 
fractal noise. The harmonic portion of the spectrum can further be subdivided into 3 main 
power components:  very low frequency (VLF; harmonic noise), low frequency (LF; 
primarily represents sympathetic neural oscillations of HR), and high frequency (HF; 
indicative of vagal modulation of HR; 2). Total power (TP) represents the complete 
power of the harmonic spectrum (2). The ratio of LF:HF, although controversial, is said to 
provide insight into the sympathovagal influences contributing to the alterations in HR by 
the autonomic nervous system (40).  The ratio of HF: TP provides information regarding 
the parasympathetic modulation of HR (27).  CGSA allows for more accurate quantitative 
analysis of HRV by acquiring clearer peaks in the LF and HF components of the power 
spectrum (42). This type of analysis is particularly useful in clinical populations who have 
reduced harmonic spectral power and preserved non-harmonic or fractal power, such as 
those with hypertension (32).  
The effects of acute exercise on HRV have been under-investigated and the 
available data provides evidence both for and against acute changes in HR modulation 
immediately following an exercise bout. For example, with respect to aerobic exercise, 
Javorka and colleagues (16) observed increased HF power and decreased LF power 
following an acute bout (12 minutes) of bench step climbs in 17 healthy normotensive 
males (20 ± 0.2 years) (16). The authors attributed these findings to an increase in 
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parasympathetic tone upon the cessation of exercise. Similarly, the findings of Raczak et 
al. (38), who investigated the effects of 30 minutes of constant treadmill exercise on 
post-exercise HRV in 18 healthy men (20 - 24 years old), support augmented 
parasympathetic activity following aerobic exercise (38). In contrast, other studies have 
shown decreases in post-exercise HRV. A population of 10 healthy, normotensive, 
sedentary men (24.6 ± 0.6 years) who engaged in both interval (45 minutes) and steady 
state (time adjusted so participants produced the same amount of work as interval 
exercise) cycling exercise, on separate occasions, exhibited decreases in spectral 
indices of autonomic function (LF, HF, TP; 31). In accordance with these findings, 13 
masters athletes (men and women; regular cyclers; 52.1 ± 3.3 years) who engaged in 25 
- 35 minutes of incremental cycling until a lactate threshold of 4.5 mmol was observed, 
showed post-exercise decreases in indices of sympathetic, parasympathetic, and total 
autonomic nervous system function (TP, VLF, LF and HF; 4).  
Few studies have investigated the acute autonomic responses to resistance 
exercise, yet like aerobic exercise, the findings are somewhat equivocal.  Rezk and 
colleagues (39) investigated the effects of whole body resistance exercise (3 sets of 20 
repetitions) on acute HRV in 17 healthy men (n = 8) and women (n = 9) (~23 years old), 
and observed increases in LF, reductions in HF, and no change in TP (39).  In contrast, 
Heffernan and colleagues (14) investigated the effect of whole body resistance exercise 
(3 sets of 10 repetitions) on acute HRV in 14 healthy young men (21 - 29 years old), and 
observed reductions in TP, LF, and HF (14).  
To our knowledge, only one study has investigated the acute effects of a bout of 
IHG on HRV. Millar and colleagues (30) recently found that an acute bout of bilateral IHG 
(4, 30% MVC contractions, sustained for 2-minutes with alternate hands, separated by a 
1-minute rest period) improves vagal modulation of HR in 18 healthy, older (70 ± 5 
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years) individuals (females = 9). As this study was performed in normotensive 
individuals, further investigation of the effects of acute IHG on HRV in individuals with 
hypertension is needed.  
Currently, there are no studies investigating the effects of exercise training on the 
acute HRV responses to a bout of aerobic, resistance or isometric exercise.  
The present study was designed to address the following research questions: 1) 
Does an acute bout of IHG cause sustained reductions in ABP (PEH) and improvements 
in vagal modulation of HR in individuals with HT? and, 2) Does 8-weeks of IHG training 
alter these responses? We hypothesized that an acute bout of IHG would elicit a PEH 
response and improve vagal modulation.  We further hypothesized that we would see an 
attenuated post-training PEH response, as PEH has been attributed to alterations in 
autonomic function, we also expected that post-IHG increases in vagal modulation of HR 
(30) would be attenuated with training. 
Participants and Methods: 
 Participants.  Twenty-five hypertensives, all of who were receiving 
pharmacotherapy to treat their hypertension and who had been medicated for at least 4 
months, participated in this investigation. Five participants voluntarily withdrew from the 
investigation (2 in IHG training group, 3 in the control group), as time commitments 
interfered with study participation. Participants were excluded if they had diabetes, a 
paced heart rhythm at rest, frequent ventricular premature heartbeats, heart failure, or if 
they had any physical limitation that would have prevented them from performing IHG 
exercise. Vasoactive medications, external exercise sessions, and nutritional status 
remained unchanged throughout the investigation. Participant characteristics are 
presented in Table 1. The Research Ethics Board of the University of Windsor approved 
the investigation, and all participants provided written, informed consent. 
 64 
Table 1: Baseline characteristics of participants 
Participants 
All                 
(N = 25) 
Training Group 
(n = 11) 
Control Group 
(n = 9) 
Females (n) 13 4 6 
Age (years) 61 ± 8.2 60.0 ± 8.5 62.7 ± 6.1 
BMI (kg/m2) 30.8 ± 7.2 31.7 ± 7.5 31.0 ± 8.8 
Systolic Blood Pressure (SBP; mmHg) 114.6 ± 11.3 113.9 ± 12.7 117.8 ± 14.3 
Diastolic Blood Pressure (DBP; mmHg) 67.5 ± 10.3 60.7 ± 11.6 67.5 ± 4.2 
Heart Rate (beats/min) 66.9 ± 10.8 62.8 ± 8.5 69.5 ± 15.3 
Medication: (n) 
   Diuretic 2 2 1 
   Angiotensin Converting Enzyme (ACE) 3 1 1 
   Aldosterone Receptor Blocker (ARB) 3 1 1 
   Calcium Channel Blocker (CCB) 3 2 0 
   Diuretic + ACE 1 1 0 
   Diuretic + ARB 3 1 1 
   ACE + Beta Blocker (BB) 3 1 1 
   ARB + CCB 1 0 1 
   ARB + BB 1 1 0 
   Diuretic + ACE + BB 2 1 1 
   Diuretic + ARB + BB 1 0 1 
   Diuretic + ARB + CCB 1 0 0 
   Diuretic + ARB + CCB + BB  1 1 0 
Values are mean ± S.D. 
  
All participants completed a medical questionnaire, and were habituated to the 
testing procedures. Following habituation, participants were randomized to an IHG 
training group or a non-exercising control group (GraphPad Prism 5, GraphPad Software 
Inc, La Jolla, CA, USA). Participants assigned to the IHG training group were instructed 
on the proper IHG exercise techniques. 
Study design. This investigation employed a between-subject repeated 
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measures design. ABP and HRV were measured prior to and following a bout of IHG 
exercise (4 sets of 2-minute isometric contractions (using alternate hands) on a 
programmed handgrip dynamometer (ZonaPLUS, Zona HEALTH, Boise, ID, USA) at 
30% MVC, each separated by 1-minute rest intervals (26,27,29), and were assessed at 
baseline, and after 4- and 8- weeks of IHG training (or no training for the control group).  
 Exercise training protocol. Participants assigned to the IHG training group 
trained 3 times per week for 8 weeks using the above-described IHG protocol. Two 
training sessions per week took place under the direct supervision of an exercise trainer, 
and the third session was conducted in the participants’ home. Participants were 
provided with detailed IHG instructions to ensure proper at home training. To establish 
similar face time with study investigators, participants randomized to the non-exercising 
control group visited the laboratory 2 times per week to have their resting ABP measured 
(29).  
 Testing protocol. All data was acquired while participants were seated with their 
right arm adjusted adjacent to the body at heart level and their feet flat on the floor (37). 
All IHG bouts were performed with the participant in the seated position with their training 
arm (which alternated with each contractions) placed on a table directly in front of them. 
Their lower arm rested on the table at a 90° angle from the upper arm.  All testing was 
conducted in the morning, in a quiet, temperature-controlled room, following a light 
breakfast, a 24-hour abstinence from alcohol and exercise and a 12-hour abstinence 
from caffeine (27).  Participants were asked to void their bladder prior to all testing 
session to minimize the effects of bladder distension on blood pressure (7). 
A schematic of the testing protocol is depicted in Figure 10.  In brief, prior to an 
acute bout of IHG exercise (4 sets of 2-minute bilateral isometric contractions at 30% 
MVC, each separated by a 1 minute rest period; ZonaPLUS, Zona HEALTH, Boise, ID, 
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USA) (26,27,40), pre-ABP and HR were measured in the right arm using brachial artery 
osciollometry (Dinamap ProCare 100, Critikon, Tampa, FL, USA; cuff 23–33 cm) after 10 
minutes of seated rest (37). R-R interval HR data was recorded for 10 minutes for later 
analysis of pre-IHG HRV. R-R intervals were acquired using standard 
electrocardiography (ECG), whereby a set of 3 electrodes was placed on the 
participants’ chest. To minimize lead placement errors, the same investigator performed 
the ECG setup at all testing sessions (3). Following this data collection period, 
participants performed an acute bout of IHG exercise. Immediately following the last rest 
interval, HR was recorded for 10 minutes for later assessment of post-IHG HRV, and 
ABP and HR were re-assessed. ABP and HR were evaluated after 1 hour and 2 hours 
post-exercise in the laboratory setting (Dinamap ProCare 100, Critikon, Tampa, FL, 
USA; 21). Following the final in-house ABP assessment, an additional 20-hours of post-
IHG ABP and HR were acquired (Spacelabs 90207 Ambulatory Blood Pressure Monitor, 
SpaceLabs Inc., Redmond, WA, USA) to allow for a comprehensive 22 hour post-
exercise evaluation of ABP and HR period to be captured (post-IHG ambulatory ABP 
and HR; 36). 
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Figure 10- Testing protocol schematic 
 
Data Analysis:  
Pre-IHG ABP and HR and on-site post-IHG ABP and HR (immediately, 1 
hour, and 2 hours post-IHG):  Four pre-IHG ABP and HR values were acquired, each 
separated by 2 minutes (Dinamap ProCare 100, Critikon, Tampa, FL, USA) by the same 
trained investigator following a 10-minute rest period (42). The latter 3 measures were 
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averaged and used in the final analysis (42). Following a bout of IHG exercise, ABP and 
HR were again acquired, using the same technique previously described.  
Off-site post-IHG ABP and HR: Post-IHG ABPs and HRs were recorded 2 times 
per hour during daytime hours (6 am – 10 pm), and 1 time per hour during nighttime 
hours (10 pm – 6 am) over the time period spanning 3 hours to 22 hours post-IHG 
exercise using an ambulatory brachial artery oscillometric device (Spacelabs 90207 
Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, WA, USA) (22). Values 
were averaged during each hour, during each time period (daytime and nighttime), and 
during the entire 20-hour ambulatory period. 
Pre- and Post-IHG HRV analysis:  Beat-to-beat HR was acquired pre- and post-
IHG using standard electrocardiography (ECG), as previously described (3). HR signal 
output was sampled at a frequency of 1,000 Hz. The analogue signals were converted to 
digital signals using a data acquisition board (PowerLab 8/30, ADInstruments Inc., 
Colorado Springs, CO, USA) for off-line beat-to-beat analysis. Ensemble averages of 
256 beat sequences were taken from a minimum time series of 400 beats (28). Ectopic 
beats were edited and replaced via linear interpolation from adjacent cardiac cycles (28). 
Only tracings with ≤5% ectopy-corrected beats were accepted for analysis (28), thus 2 of 
the 20 participants (both of whom were in the training group) were excluded from the 
HRV analysis. To assess HRV, these R-R (i.e. pulse) intervals were then submitted to 
CGSA (28,43). 
Statistical Analysis: 
One-way ANOVAs (group) of baseline pre-IHG ABP, pre-IHG HR and pre-IHG 
HRV were employed to determine if baseline differences existed between the training 
and control groups at baseline. As no differences were revealed (P ≥ 0.05), two-way 
ANOVAs (group x phase) with repeated measures (time) were used to analyze pre-IHG 
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to post-IHG alterations in ABP (SBP and DBP), HR and HRV (VLF, LF, HF, TP, LF:HF 
ratio, HF:TP ratio). Where applicable, post-hoc analyses were conducted using paired-
sample t-tests, which used Bonferroni corrected alpha levels. 
All data was re-assessed after separately controlling for, as between subject 
factors, gender (male or female), medication (single or multiple medications) and 
baseline ABP (controlled to within the normal range (≤120/80 mmHg) or uncontrolled 
(≥120/80 mmHg)). 
Statistical significance was set at P ≤ 0.05. Analysis of data was completed using 
IBM (PASW) SPSS Statistics 18 (SPSS Inc., Chicago, IL, USA).  
Results:  
Acute cardiovascular effects of IHG exercise 
Immediately following a bout of IHG exercise, analyses of variance revealed no 
significant differences in SBP or DBP pre- to post-IHG (all P ≥ 0.05) in either the IHG 
training (Pre-IHG: 118 ± 14 and 67± 4 mmHg to Post: 117 ± 13 and 70 ± 6 mmHg in SBP 
and DBP, respectively), or control group (Pre-IHG: 114 ± 13 and 61 ± 12 mmHg, Post-
IHG: 114 ± 10 and 62 ± 10 mmHg in SBP and DBP, respectively). 
 In both groups, SBP was significantly elevated above pre-IHG levels from 2 - 7 
hours following acute IHG (Training: 126 ± 16 mmHg, 134 ± 11 mmHg, 133 ± 17 mmHg, 
132 ± 11 mmHg, 132 ± 12 mmHg, and 133 ± 16 mmHg, respectively; Control: 126 ± 14 
mmHg, 141 ± 13 mmHg, 139 ± 14 mmHg, 131 ± 13 mmHg, 129 ± 14 mmHg, and 126 ± 
19 mmHg, respectively) and again from 18 - 22 hours post-IHG (Training: 122 ± 10 
mmHg, 130 ± 10 mmHg, 127 ± 14 mmHg, 124 ± 14 mmHg, and 124 ± 14 mmHg, 
respectively; Control: 133 ± 18 mmHg, 135 ± 19 mmHg, 135 ± 23 mmHg, 133 ± 20 
mmHg, and 131 ± 18 mmHg, respectively) (all P ≤ 0.005; Figure 11).  
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Figure 11: The 22-hour SBP response to acute IHG exercise. Hour 0 denotes pre-
IHG SBP value. * Significantly different from pre-IHG values. P ≤ 0.005; N = 20.  
 
From 1 - 8 hours following IHG exercise, DBP remained significantly elevated 
above pre-IHG DBP values (P ≤ 0.003) in both groups (Training: 72 ± 5 mmHg, 76 ± 10 
mmHg, 78 ± 10 mmHg, 78 ± 14 mmHg, 79 ± 10 mmHg, 80 ± 11 mmHg, 80 ± 11 mmHg, 
and 79 ± 13 mmHg, respectively; Control: 63 ± 9 mmHg, 66 ± 9 mmHg, 84 ± 12 mmHg, 
76 ± 12 mmHg, 72 ± 11 mmHg, 70 ± 7 mmHg, 71 ± 9 mmHg, and 66 ± 9 mmHg, 
respectively). At 19 - 22 hours post-IHG, there was a significant increase in DBP when 
compared to pre-IHG DBPs (Training: 77 ± 13 mmHg, 75 ± 14 mmHg, 76 ± 15 mmHg, 
and 77 ± 10 mmHg, respectively; Control: 76 ± 18 mmHg, 77 ± 15 mmHg, 79 ± 13 
mmHg, and 76 ± 16 mmHg, respectively; P ≤ 0.001). The 22-hour post-IHG SBP and 
DBP responses are shown in Figures 11 and 12, respectively. 
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Figure 12: The 22-hour DBP response to acute IHG exercise. Hour 0 denotes pre-
IHG DBP value.  * Significantly different from pre-IHG values. P ≤ 0.003; N = 20.  
 
HR was significantly reduced immediately post-IHG compared to pre-IHG HR (P 
< 0.001) in both the training (Pre-IHG: 69 ± 17beats/min to Post-IHG: 66 ± 15beats/min 
and control groups (Pre-IHG: 63 ± 9beats/min to Post-IHG: 60 ± 9beats/min). Post-IHG 
HR remained significantly lower than pre-IHG values for 2 hours following the IHG 
exercise (Training: 63 ± 12beats/min, and 64 ± 16beats/min; Control: 59 ± 9beats/min, 
59±11beats/min; P < 0.001). HR returned to pre-IHG levels for the remainder of the test 
period (3 - 22 hours post-IHG; all P ≥ 0.005). The 22-hour post-IHG HR responses are 
shown in Figure 13. 
All data was re-assessed after separately controlling for gender, medication, and 
baseline ABP, and no significant effects were revealed (all P ≥ 0.05). 
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Figure 13: The 22-hour HR response to acute IHG exercise. Hour 0 denotes the pre-   
IHG HR value. * Significantly different from pre-IHG values. P < 0.001, N = 20. 
 
Following an acute bout of IHG exercise, analyses of variance of the harmonic 
components of HRV (VLF, LF, HF, TP, LF/HF, and HF/TP) revealed no significant effects 
(all P ≥ 0.3) (Table 2). 
Effects of IHG training on acute cardiovascular responses 
Acute ABP and HR responses to IHG were measured following both 4- and 8-
weeks of IHG training (or no-training for the control group). After 4-weeks of IHG training, 
the SBP response to IHG in both groups was similar to baseline measures. Immediately 
following IHG exercise, SBP remained unchanged from pre-IHG SBP values (P = 0.3). 
From 1 - 7 hours and 16 - 22 hours post-IHG, SBP was significantly elevated compared 
to pre-IHG SBP values (P ≤ 0.002). Following 8-weeks of IHG training, the SBP 
response to IHG exercise remained similar to the responses observed at baseline and 4-
weeks post-training. Again, SBP remained unchanged from pre-IHG values immediately 
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following an acute bout of IHG, yet it was significantly elevated above pre-IHG values 
from 1 - 7 hours and 17 - 20 hours post-IHG (P ≤ 0.002).  
Following 4-weeks of IHG training (or no-training for the control group), post-IHG 
DBP did not significantly change from pre-IHG DBP values (P = 0.1) in either group. 
Similar to pre-training, from 1 to 7, 15 to 17, and 19 hours post-IHG, there was a 
significant increase in DBP, as compared to pre-IHG DBP values (P ≤ 0.005). Following 
8-weeks of IHG training (or no-training for the control group), DBP immediately following 
IHG was significantly increased when compared to pre-IHG DBP values (P = 0.003). 
During the first hour post-IHG, DBP returned to pre-IHG values. However, DBP again 
increased significantly from pre-IHG levels from 2 - 7 and 18 - 20 hours post-IHG (all P ≤ 
0.002).     
Similar to pre-training, HR was significantly reduced following a bout of IHG 
exercise (P = 0.002) in both training and control group following 4-weeks of IHG training. 
The reduction in HR was only observed immediately following the IHG bout, as 1 - 22 
hour post-IHG HR remained unchanged from pre-IHG HR values (P ≥ 0.005). Post-
training there were no significant changes in HR, following an acute bout of IHG for 
either group, at any time point.  
Two-way ANOVAs of mean 24-hour ambulatory ABP and HR, nighttime ABP and 
HR, and daytime ABP and HR revealed no significant main effects or interactions (P ≥ 
0.6) (Data not presented).     
With respect to HRV, significant differences in pre- to post-IHG VLF, LF, HF, TP, 
LF:HF ratio, or HF:TP ratio were not observed (P ≥ 0.05) in the training group following 
4- or 8-weeks of IHG training, when compared to the non-exercising control group. For 
HF power, however, there was a significant interaction between group and phase (P = 
0.05) (Table 2), yet post-hoc analysis revealed no significant difference between pre- 
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and post-IHG alterations in HF power at baseline, after 4-weeks of training, or after 8-
weeks of training (all P ≥ 0.07).  
Table 2: HRV indices pre- and post-IHG at baseline, after 4- and 8- weeks of training 
 Baseline After 4-weeks of IHG training After 8-weeks of IHG training 
 Pre-IHG Post-IHG Pre-IHG Post-IHG Pre-IHG Post-IHG 
VLF (ms2) 
Training 
Control 
 
203.7 ± 275.0 
158.0 ± 122.7 
 
295.3 ± 547.9 
64.6 ± 71.2 
 
99.2 ± 86.0 
99.4 ± 86.2 
 
110.7 ± 83.1 
59.8 ± 45.9 
 
113.0 ± 132.0 
98.6 ± 107.7 
 
75.7 ± 52.3 
101.2 ± 100.9 
LF (ms2) 
Training 
Control 
 
86.9 ± 144.1 
108.2 ± 120.6 
 
120.1 ± 193.4 
53.4 ± 77.4 
 
50.7 ± 33.6 
76.2 ± 64.3 
 
64.2 ± 77.4 
82.7 ± 123.8 
 
47.7 ± 48.3 
47.7 ± 61.3 
 
40.0 ± 30.7 
103.9 ± 135.6 
HF (ms2) 
Training 
Control 
 
65.0 ± 103.6 
93.0±124.0 
 
64.8 ± 92.1 
45.3 ± 48.8 
 
102.7 ± 119.6 
41.5 ± 33.2 
 
106.2 ± 132.8 
28.2 ± 24.9 
 
83.8 ± 109.1 
73.1 ± 91.5 
 
165.1 ± 240.1 
109.1 ± 112.8 
TP (ms2) 
Training 
Control 
 
355.6 ± 486.7 
359.2 ± 323.7 
 
480.2 ± 766.2 
163.3 ± 140.3 
 
252.7 ± 211.8 
217.1 ± 124.1 
 
281.1 ± 213.0 
170.7 ± 143.6 
 
244.4 ± 252.6 
219.4 ± 172.9 
 
280.9 ± 266.7 
314.1 ± 245.0 
LF/HF (ms2) 
Training 
Control 
 
2.1 ± 2.1 
3.1 ± 6.1 
 
5.1 ± 6.9 
3.7 ± 8.1 
 
0.8 ± 0.8 
3.8 ± 4.9 
 
0.9 ± 0.6 
7.9 ± 15.7 
 
3.2 ± 5.6 
1.6 ± 2.5 
 
2.0 ± 4.3 
1.4 ± 1.5 
HF/TP (ms2) 
Training 
Control 
 
0.3 ± 0.2 
0.2 ± 0.1 
 
0.4 ± 0.3 
0.4 ± 0.4 
 
0.4 ± 0.2 
0.2 ± 0.2 
 
0.4 ± 0.2 
0.3 ± 0.3 
 
0.4 ± 0.3 
0.3 ± 0.3 
 
0.4 ± 0.2 
0.4 ± 0.3 
Values are mean ± S.D. N = 20 (training group: n = 9; control group: n = 9). 
 
Discussion: 
 In healthy individuals, an acute bout of IHG elicits an immediate reduction in post-
exercise ABP and an improvement in vagal HR modulation (30). Unknown was whether: 
1) this ABP reduction is sustained (PEH), a finding which would be of great benefit to 
individuals with elevated resting ABP (HT), 2) acute post-IHG increases in vagal 
modulation also occur in hypertensives, a population with compromised autonomic 
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function, and/or 3) these collective responses change with chronic exposure to the IHG 
stimulus. The purpose of this investigation was to address the hypotheses that an acute 
bout of IHG would cause sustained reductions in ABP (PEH) and improve vagal 
modulation of HR in individuals with HT and that 8-weeks of IHG training would attenuate 
these post-IHG responses. Three prominent and novel findings emerged from this study: 
in medicated hypertensives 1) an acute bout of IHG does not elicit a PEH response, 2) 
acute IHG exercise does cause post-exercise improvement in vagal modulation of HR, 
and 3) 8-weeks of IHG training does not alter these acute responses.  
Acute cardiovascular effects of IHG exercise 
Contrary to our hypothesis, an acute bout of IHG exercise did not elicit a PEH 
response. Although reductions in SBP (~3 mmHg) have been observed 5-minutes 
following IHG exercise in healthy older individuals, this did not translate to sustained 
ABP reductions (PEH) in our population of medicated hypertensives (30). In contrast, 
SBP and DBP were both elevated above pre-IHG values for the first 5 - 6 hours following 
IHG exercise, followed by increases in ABP from 15 - 21 hours post-exercise. We do not 
consider this rise to be concerning, however, as all post-IHG values remained within the 
normal ambulatory ABP range. The lack of a DBP response to an acute bout of IHG in 
this investigation, however, is in line with the findings of Millar and colleagues (30).   
Why did we not see a sustained reduction in ABP (PEH) following IHG? The 
population in the current study was one of well-controlled medicated hypertensive 
individuals (mean resting ABP for the training group: ~114/61 mmHg and for the control 
group: ~118/68 mmHg) with well-balanced medication regimens between the two groups 
(Table 1), whereas the population in the study by Millar and colleagues (30) had higher 
initial ABP (mean resting ABP: 125/74 mmHg). These findings suggest that initial resting 
ABP may influence the acute hypotensive response to IHG exercise, just as it does with 
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aerobic exercise. Additionally, many mechanisms have been suggested to play a role in 
post-aerobic exercise PEH, one of which is a reduction in cardiac output. Following an 
acute bout of aerobic exercise, individuals with HT have sustained reductions in cardiac 
output (26), likely due to a reduction in blood volume, leading to a consequent reduction 
in stroke volume and ABP (as ABP is the product of cardiac output (stroke volume and 
heart rate) and total peripheral resistance (TPR; 20)). Acute resistance exercise also 
elicits post-exercise reductions in cardiac output, which again have been attributed to 
post-exercise reductions in stroke volume (39). Unlike aerobic and resistance exercises, 
IHG exercise may not provide a large enough stimulus or been an effective enough 
stimulus in our population of medicated hypertensives to evoke a reduction in blood 
volume (sustained or otherwise), leaving stroke volume and cardiac output unaltered and 
post-IHG ABP unchanged. Future work should investigate the effects of IHG exercise on 
blood volume, stroke volume and cardiac output alterations. 
 TPR itself is another mechanism thought to be responsible for the PEH response 
following aerobic exercise. Reductions in TPR have been observed in hypertensive 
individuals following an acute bout of aerobic exercise (27). As aerobic exercise is a 
dynamic exercise involving large muscle groups, local vasodilation in the vasculature of 
the large muscle masses could account for the ABP reduction post-exercise. IHG 
exercise, however, only uses the small muscles of the forearm. The stimulus from IHG 
exercise increases vasodilatory capacity and conductance, and lowers resistance in the 
forearm vasculature (26); however, these changes may not provide a large enough 
alteration, or be sustained for an extended period of time, to evoke systemic changes in 
TPR and evoke a PEH response post-IHG. Furthermore, it is generally accepted that 
following aerobic exercise there is a marked decrease in sympathetic nerve activity and 
an increase in parasympathetic activity (20), and this modulation has been attributed to 
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the PEH response (20, 30). The lack of reduction in sympathetic outflow (11), and the 
collective lack of alteration in autonomic function following IHG exercise in this study 
(discussed below) may also be responsible for the absent PEH response following IHG 
exercise in our population of medicated hypertensives.   
The elevations as opposed to the anticipated reductions in post-exercise ABP 
may have occurred for a number of reasons, including acute anxiety, ambulatory 
activities, and early morning rises in ABP.  As participants were required to remain in the 
laboratory for the first 2 hours post-exercise, ABP may have been influenced by the their 
anticipation of leaving the laboratory (33). This was evident by repeat questions of “is it 
time to go yet?” or “how much longer.”  With respect to the novel measures of post-
exercise ABP using an ambulatory device, increases in SBP and DBP seen in the first 5 
- 6 hours following the IHG exercise were likely due to the ambulatory activity of the 
participants. In an attempt to mimic activities of daily living in the general hypertensive 
population, activities following laboratory testing were not controlled. For example, many 
participants returned to work immediately following the study, which could explain the 
observed SBP and DBP increases. The increases in ABP seen from 15 - 21 hours post-
exercise occurred during the waking times of the participants, 3 am – 9 am, associated 
with increases in ABP (13).     
 Unlike ABP, there was a significant reduction in HR immediately following IHG 
exercise (~3 beats/min). This finding is unlike the HR findings of Millar and colleagues 
(30), as no significant differences (increase or decrease) in HR following IHG exercise 
were observed. Increases in HR, with subsequent increases in cardiac output, have also 
been noted following aerobic exercise (20). The variation in HR responses to exercise 
may be attributed to the set point of the baroreflex and/or alterations in autonomic 
function following isometric exercise. As the participants in the current study experienced 
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reductions in HR following exercise, with no alterations in autonomic function (HRV), the 
HR reduction is most likely due to acute alterations in baroreflex sensitivity post-exercise 
in effort to offset the rise in ABP (20). Alternatively, the reduction in HR observed 
following IHG exercise might simply have been due to normal fluctuations in HR that fell 
within the range of statistical significance.  
Autonomic function was not altered by an acute bout of IHG in our study 
population. This finding did not support our hypothesis that vagal modulation of HR 
would be improved following a bout of IHG exercise. Again, these findings are in contrast 
with the results observed by Millar and colleagues (30), who found marked increases in 
parasympathetic activity following IHG exercise. As previously noted, all participants in 
the current study were medicated for hypertension, some of whom were on medications 
known to increase autonomic function. For example, beta-blockers (BBs) and 
angiotensin converting enzyme inhibitors (ACE inhibitors) have been shown to not only 
improve ABP, but also improve HRV after 1 month (20,21).  As more than half of the 
individuals in both our training group and the study population as a whole (Table 1) were 
on one or a combination of these drugs, and had been medicated for at least 4 months 
before beginning the study, the participants may have reached their capacity for maximal 
autonomic improvements. As such, these medications may have contributed to the lack 
of a post-IHG alteration in vagal modulation of HR. 
Effects of IHG training on the acute cardiovascular responses 
To date, there is no documentation of the effects of training on the PEH 
response. In the current study, post-exercise increases in ABP remained unaltered with 
4- and 8-weeks of IHG training. These findings suggest chronic exposure to the acute 
IHG stimulus does not alter the physiological responses to IHG exercise nor does it 
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change the responses to align with our original hypothesis. Again, initial resting ABPs 
and medications likely played a role in the lack of change with training. Although 
normotensive individuals have shown small PEH responses, these findings are 
inconsistent (20). As individuals in this study had ABPs already within the normal range, 
the capacity for a PEH response, and therefore a change in this response, was limited.  
Remarkably, the acute response to the IHG stimulus was replicated almost identically 
after 4- and 8- weeks of training. This supports the theory that the individuals in this 
study were much like normotensive individuals, and as such, had a limited ability to alter 
their response to the IHG stimulus with training. 
After 4-weeks of IHG training, post-IHG HR reductions were similar to those 
observed at baseline, however, after 8-weeks of IHG training, this response was no 
longer present. It is possible that testing-anxiety or alterations in breathing are 
responsible for this change in HR response to the IHG stimulus. Feeling of anxiety 
towards the testing session is unlikely, as participants had taken part in testing on prior 
occasions, however situational anxiety cannot be ruled out. Contrarily, the lack of a 
reduction in HR post-IHG following 8-weeks of training may simply be due to minute-to-
minute fluctuations in HR.  
IHG training did not alter the post-exercise autonomic response to an acute bout 
of IHG exercise, and thus did not support our hypothesis of an attenuated increase in 
vagal modulation of HR following acute IHG.  As with the post-training acute ABP 
responses to the IHG stimulus, medications likely played a role in the lack of alterations 
in post-exercise HRV following training. As previously mentioned, participants may have 
experienced maximum benefits from medication, and therefore, had little to no room for 
improvement or changes in indices of HRV.  
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Conclusions and Future Direction:  
This investigation revealed the novel findings that an acute bout of IHG does not 
cause sustained reductions in ABP (PEH) nor does it improve vagal modulation of HR in 
a population of well-controlled medicated hypertensives, and these responses are 
unchanged with 8-weeks of IHG training. Future studies should investigate the acute and 
chronic effects of IHG on post-exercise ABP and HRV in individuals medicated for 
hypertension with resting ABP values above the normal range (> 120/80 mmHg), and/or 
in unmedicated hypertensives with resting ABP > 140/90 mmHg. 
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CHAPTER 4: Effects of isometric handgrip training on resting and 24-hour 
ambulatory arterial blood pressure and heart rate variability in individuals 
medicated for hypertension 
(To be submitted to: Journal of Hypertension) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
Hypertension (HT), a disease characterized by sustained elevations in resting 
arterial blood pressure (ABP) and autonomic dysfunction (35), is a prominent risk factor 
for the world’s leading cause of death, cardiovascular disease (CVD; 28). It afflicts 1 in 3 
Americans (28) and accounts for 77 billion dollars in health care spending in the United 
States (17). Aerobic exercise training (walking, running, and cycling, 1 to 7 days/week, 
for 30-60 minutes, at 30 to 90% maximum oxygen consumption) significantly reduces 
resting systolic ABP (SBP; ~7 mmHg) and diastolic ABP (DBP; ~6 mmHg) in individuals 
with HT (30). Resistance exercise training (1 set of 10 repetitions of all the major muscle 
groups, 2 - 3 times per week; 1) is recommended as an adjunct to aerobic exercise 
training, as the weight of the evidence also supports a reduction in resting ABP (~3 
mmHg in both SBP and DBP) (14).  
Though resting ABP provides general risk stratification for HT, ambulatory ABP is 
more efficacious in predicting CVD related events than clinical resting ABP measures 
(31). Aerobic exercise training (walking, running, or cycling, 1 to 7 days/week, for 15-63 
minutes, at 30 to 88% heart rate reserve) has been shown to reduce ambulatory ABP 
(6). Meta-analyses of aerobic training and ambulatory ABP support reductions in daytime 
SBP and DBP of  ~3 mmHg and ~2 mmHg, respectively, while nighttime ABP decreased 
by ~3 mmHg for both SBP and DBP. Although resistance exercise training and its effect 
on 24-hour ambulatory ABP has been investigated to a lesser extent, available evidence 
does not support post-training reductions in ambulatory ABP (6). 
Isometric handgrip (IHG) training (4, 2-minute bilateral isometric contractions 
performed at 30% of maximal voluntary contraction and separated by a timed rest 
period, 3X/week for 8 -10 weeks) is a novel and less time consuming form of exercise 
training repeatedly shown to reduce resting ABP in small scale investigations in 
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individuals with and without HT (14,20,21,25). However, the effects of IHG training on 
ambulatory ABP are unknown. To date, no randomized controlled trials have examined 
the effects of IHG training on resting ABP concomitant with ambulatory ABP.  
Spectral analysis of heart rate variability (HRV) is a popular non-invasive tool 
used to assess autonomic function, and provides insight into the contributions of the 
parasympathetic and sympathetic nervous system (PNS and SNS, respectively) to HR 
modulation (35). Coarse graining spectral analysis (CGSA) is a non-invasive frequency 
domain analysis method that yields both harmonic and non-harmonic components of the 
HRV signal. The harmonic portion of the spectrum is subdivided into very low frequency 
(VLF; harmonic noise), low frequency (LF; primarily represents sympathetic neural 
oscillations of HR), and high frequency (HF; vagal modulation of HR; 4) components, 
with total power (TP) reflecting the complete power of the harmonic spectrum (4). 
Although controversial, the ratio of LF: HF is said to provide insight into the 
sympathovagal influences contributing to the alterations in HR by the autonomic nervous 
system (35). The ratio of HF: TP is indicative of parasympathetic modulation of HR (22). 
CGSA allows for more accurate quantitative analysis of HRV by acquiring clearer peaks 
in the LF and HF components of the power spectrum (39). This type of analysis is 
particularly useful in clinical populations who have reduced harmonic spectral power and 
preserved non-harmonic or fractal power, such as those with HT (29). 
The effects of aerobic training on heart rate variability (HRV) have been 
thoroughly investigated, and although the findings are somewhat inconclusive in young 
healthy individuals, the evidence suggests that older individuals and patient populations 
(i.e., post-myocardial infarction (post-MI) patients) experience marked improvements in 
HRV following aerobic, resistance and IHG training (9,13,18,33,34,35). For example, 8- 
weeks of cycling exercise and calisthenics (1 hour, 5 times per week at 80% HRmax) 
 88 
significantly increased parasympathetic modulation of HR (increase HF power) and 
decreased sympathetic modulation of HR (decreased LF power) in 22 post-MI individuals 
(52 ± 7 years; 21). In 88 older (57 ± 6 years) post-menopausal women, 8- weeks of 
running and/or cycling (120 - 165 minutes, 3 - 4 times per week, at 50% VO2max) 
significantly increased both sympathetic and parasympathetic modulation of HR 
(increased LF and HF power; 13). 
The effects of resistance training on HRV have been investigated to a lesser 
degree; however, the results continue to support improvements in HRV with training in 
clinical populations. In an early study examining the effects of 3 months of resistance 
training (whole body circuit training, at a moderate intensity, 3 times per week) in 39 
individuals with chronic heart failure (65 ± 11 years; 23), significant increases in 
parasympathetic tone and reductions in sympathetic tone were observed following 
training (increase in HF power and decrease in LF power). More recently, the effects of 
16-weeks of resistance exercise (30 minutes circuit training, 8 - 12 repetitions, 50-80% of 
1 repetition maximum, 2 times per week) were examined in 19 women (27 - 60 years 
old) with Fibromyalgia who had blunted pre-training HRV (9). Investigators observed 
increases in total autonomic modulation of HR (TP) and increased parasympathetic 
control of HR (HF power) post-training.  
To date, only one study has investigated the effects of IHG training on HRV and 
like with the aerobic and resistance training literature, this form of training also appears 
to positively influence autonomic modulation of HR.  For example, following 10-weeks of 
IHG training (4, 30% MVC contractions, sustained for 2-minutes with alternate hands, 
separated by a 1-minute rest period, 3x/week), investigators found an increase in resting 
vagal tone (increase in HF power) in 17 older (60 - 80 years old) hypertensives (some of 
whom were on medication to treat their hypertension; 35).  
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Over 29% of people in the United States have HT, yet only 78% of these individuals are 
aware of their HT. Importantly, of those who are aware of their HT, only 64% are 
successfully treated to target ABP values (≤ 135/85 mmHg and lower) (26). Importantly, 
reductions in SBP and DBP of 2 mmHg reduce the risk of stroke by 14% and 17%, 
respectively, and the risk of coronary artery disease by 9% and 6%, respectively.  As 
hypertensive individuals have elevated ABPs and marked reductions in HRV, 
improvements in ABP and/or HRV following IHG training may have clinical relevance. 
With this knowledge, 3 important, novel research questions emerge: in a randomized 
controlled trial of medicated HTs 1) Does IHG training reduce resting ABP? 2) Does IHG 
training improve ambulatory ABP? and, 3) Does IHG training improve resting HRV? 
Therefore, the purpose of the current randomized controlled study was to address the 
hypotheses that IHG training lowers resting and ambulatory ABP and improves resting 
HRV in medicated hypertensives. 
Methods:  
 Study Participants.  Twenty-five individuals, aged ≥18 years, who had been 
receiving pharmacotherapy for HT for at least 4 months, were recruited to participate in 
this study. Baseline characteristics of participants are displayed in Table 3. Five 
individuals voluntarily withdrew from the study due to time restraints (2 in IHG training 
group, 3 in the control group). Individuals with diabetes, a paced heart rhythm at rest, 
frequent ventricular premature beats, heart failure, and those who had any physical 
limitation that would have prevented them from performing IHG exercise, were excluded 
from the study.  
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Table 3: Baseline characteristics of participants 
Participants 
All                 
(N = 25) 
Training Group 
(n = 11) 
Control Group 
(n = 9) 
Females (n) 13 4 6 
Age (years) 61 ± 8.2 60.0 ± 8.5 62.7 ± 6.1 
BMI (kg/m2) 30.8 ± 7.2 31.7 ± 7.5 31.0 ± 8.8 
Systolic Blood Pressure (SBP; mmHg) 114.6 ± 11.3 113.9 ± 12.7 117.8 ± 14.3 
Diastolic Blood Pressure (DBP; mmHg) 67.5 ± 10.3 60.7 ± 11.6 67.5 ± 4.2 
Heart Rate (beats/min) 66.9 ± 10.8 62.8 ± 8.5 69.5 ± 15.3 
Medication: (n) 
   Diuretic 2 2 1 
   Angiotensin Converting Enzyme (ACE) 3 1 1 
   Aldosterone Receptor Blocker (ARB) 3 1 1 
   Calcium Channel Blocker (CCB) 3 2 0 
   Diuretic + ACE 1 1 0 
   Diuretic + ARB 3 1 1 
   ACE + Beta Blocker (BB) 3 1 1 
   ARB + CCB 1 0 1 
   ARB + BB 1 1 0 
   Diuretic + ACE + BB 2 1 1 
   Diuretic + ARB + BB 1 0 1 
   Diuretic + ARB + CCB 1 0 0 
   Diuretic + ARB + CCB + BB  1 1 0 
Values are mean ± S.D 
 
 Study design. The University of Windsor Research Ethics Board approved this 
randomized controlled investigation, and all participants provided written informed 
consent and completed a medical questionnaire. Upon review of the medical 
questionnaire and establishment of eligibility, participants underwent familiarization of all 
testing procedures. Participants were then randomized to an IHG training group or a 
non-exercising control group. In order to blindly randomize participants into groups, 
GraphPad software was employed (GraphPad Prism 5, GraphPad Software Inc, La Jolla, 
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CA, USA). Participants assigned to the IHG training group were instructed on proper IHG 
exercise techniques. 
 Following group assignment, all participants underwent baseline-testing 
procedures, which were repeated after 4- and 8- weeks of IHG training (or no training for 
the control group).  
 Exercise Training Protocol. Participants assigned to the IHG training group 
trained 3 times per week, for a total of 8 weeks. Two training sessions per week took 
place under the direct supervision of an exercise trainer, and the third session was 
conducted in the participants’ home. Participants were provided with detailed instructions 
to ensure proper at home training, and were instructed to record their exercise, 
nutritional, and medication data in exercise log books to ensure consistency throughout 
the intervention period. 
 Each training session took approximately 30 minutes. Prior to the on-site training 
session, participants had their ABP measured (Dinamap ProCare 100, Critikon, Tampa, 
FL, USA); this data was not used for analysis. Participants then performed a bout of IHG 
exercise: 4 sets of 2-minute isometric contractions (using alternate hands) were 
performed on a programmed handgrip dynamometer (ZonaPLUS, Zona HEALTH, Boise, 
ID, USA) at 30% maximal voluntary contraction (MVC; determined at the onset of each 
exercise session via electronic linear load cells contained within each IHG device), each 
separated by a 1-minute rest interval (20,23).  
Participants randomized to the non-exercising control group visited the laboratory 2 
times per week to have their ABP measured to ensure equal face-time with investigators 
(25). 
Testing Protocol. As previously mentioned, all participants underwent testing at 
baseline, and after 4- and 8- weeks of IHG training (or no training for the control group). 
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To minimize the influence of external factors on the cardiovascular measures, 
participants were asked to refrain from the consumption of alcohol and exercise for 24 
hours prior to each testing session, and to avoid caffeine consumption for 12 hours prior 
(20). All testing was conducted in the morning, in a quiet, temperature-controlled room, 
following a light breakfast. On testing days, all participants were asked to void their 
bladder prior to the testing session to minimize the effects of bladder distension on blood 
pressure (8). 
Resting ABP and HR were measured after 10 minutes of seated rest (Dinamap 
ProCare 100, Critikon, Tampa, FL, USA; 3). R-R interval HR data was then recorded for 
10 minutes for later analysis of resting HRV, using standard electrocardiography (ECG), 
whereby a set of 3 electrodes was placed on the participants’ chest (22). To minimize 
lead placement errors, the same investigator performed the ECG setup at all testing 
sessions (5). After measuring resting ABP, HR and HRV, the participants were fitted with 
an ambulatory ABP monitoring device on their right arm, which monitored ABP and HR 
for 24-hours (Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., 
Redmond, WA, USA).  
Data Analysis:  
Resting ABP and HR:  Four ABP and HR values were acquired, each separated 
by 2 minutes (Dinamap ProCare 100, Critikon, Tampa, FL, USA) by the same trained 
investigator following a 10-minute rest period (3). The latter 3 measures were averaged 
and used in the final analysis.  
Ambulatory ABP and HR: ABPs and HRs were recorded 2 times per hour 
during daytime hours (6am - 10pm), and 1 time per hour during nighttime hours (10pm - 
6am) over a 24-hour period using an ambulatory brachial artery oscillometric device 
(Spacelabs 90207 Ambulatory Blood Pressure Monitor, SpaceLabs Inc., Redmond, WA, 
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USA) (19). Values were averaged over the entire 24-hour ambulatory period (mean 24-
hr), and during each time period (daytime and nighttime). 
Resting HRV analysis:  Beat-to-beat HR was acquired using standard 
electrocardiography (ECG), as previously described (22). HR signal output was sampled 
at a frequency of 1,000 Hz. The analogue signals were converted to digital signals using 
a data acquisition board (PowerLab 8/30, ADInstruments Inc., Colorado Springs, CO, 
USA) for off-line beat-to-beat analysis. Ensemble averages of 256 beat sequences were 
taken from a minimum time series of 400 beats (22). Ectopic beats were edited and 
replaced via linear interpolation from adjacent cardiac cycles (22). Only tracings with 
≤5% ectopy-corrected beats were accepted for analysis (22), thus 2 of the 20 
participants were excluded from the HRV analysis (both of whom were in the training 
group). To assess HRV, these R-R (i.e. pulse) intervals were then submitted to CGSA 
(22,39). 
Statistical Analysis: 
 One-way ANOVAs (group) of baseline resting ABP, 24-hour ambulatory ABP and 
HRV were employed to determine if baseline differences existed between the training 
and control groups. As no differences were revealed (P ≥ 0.05), two-way ANOVAs 
(group x time) were used to analyze resting ABP (SBP, DBP) and HR, 24-hour 
ambulatory ABP (24-hour mean ABP, nighttime ABP, and daytime ABP) and resting 
HRV (VLF, LF, HF, TP, LF: HF ratio, HF: TP ratio). Where applicable, post-hoc analyses 
were conducted using paired-sample t-tests, which used Bonferroni corrected alpha 
levels. 
All data were re-assessed after separately controlling for, as between subject 
factors, gender (male or female), medication (single or multiple medications) and 
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baseline ABP (controlled to within the normal range (≤120/80 mmHg) or uncontrolled 
(≥120/80 mmHg)). 
 The training group was further divided into IHG training responders, who experienced 
clinically significant reductions in ABP (≥ 2 mmHg; 30), and non-responders (those who 
did not achieve reductions in ABP ≥ 2 mmHg). One-way ANOVA (group) was employed 
to determine if baseline differences existed between groups for baseline ABP, age, and 
BMI. As no differences were observed (P ≥ 0.05), two-way ANOVAs (group x time) were 
employed to analyze resting ABP (SBP, DBP) and HR. We did not re-categorize our 
population into responders and non-responders for ambulatory ABP, as we were 
unaware of any existing literature specifying clinically relevant reductions in ambulatory 
ABP related to reduced CVD risk.  
Statistical significance was set at P ≤ 0.05. Results are mean ± S.D., unless 
otherwise specified. Analysis of data was completed using IBM (PASW) SPSS Statistics 
18 (SPSS Inc., Chicago, IL, USA).  
Results: 
Effects of IHG training on resting ABP and HR 
Following 4- and 8- weeks of IHG training (or no training for the control group), no 
significant changes in resting SBP, DBP, or HR were observed in either the training 
group or in the control group (all P ≥ 0.05). Results are shown in Table 4. 
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Table 4: Resting SBP and DBP at baseline, after 4- and 8-weeks of training. 
 Baseline 
After 4-weeks of 
training 
After 8-weeks of 
training 
SBP (mmHg)    
    Control Group 113.3 ± 11.8 111.4 ± 14.4 118.4 ± 15.5 
    Training Group 112.2 ± 11.0 110.9 ± 7.1 111.3 ±7.7 
DBP (mmHg)    
     Control Group 61.9 ± 12.4 60.6 ± 10.5 63.5 ± 12.4 
     Training Group 68.9 ± 7.0 66.9 ± 8.7 69.0 ± 7.4 
HR (beats/min)    
     Control Group 62.9 ± 8.6 59.9 ± 7.7 61.3 ± 9.0 
     Training Group 66.1 ± 12.0 65.6 ± 13.7 67.9 ± 14.7 
Values are mean ± S.D; all P > 0.05. N = 20 (training group: n = 11; control group: n = 9). 
 
When participants in the training group were divided into responders and non-
responders, 6 of the 11 participants experienced clinically relevant reductions in SBP 
(~9.0 ± 5.2 mmHg), while 5 of the 11 showed clinically relevant DBP reductions (~2.0 ± 
1.6 mmHg). Two-way analysis of variance of SBP revealed a significant interaction 
between time and group (P = 0.001). Post-hoc analyses showed a significant reduction 
in SBP (P = 0.008) from baseline to 8-weeks in the responder group, and no significant 
reductions in SBP (P = 0.07) in the non-responder group. No significant interactions or 
main effects were revealed for DBP or HR, for either group (P > 0.05) at any time point. 
The baseline characteristics of responders and non-responders, with respect to SBP, are 
shown in Table 5. 
 
 
 
 
 
 
 
 
 96 
Table 5: IHG training responder versus non-responder baseline characteristics 
N = 11 
Responders       
(n = 6) 
Non-responders       
(n = 5) 
Females 3 1 
Age (years) 59.0 ± 7.6 58.8 ± 9.5 
BMI (kg/m2) 35.7 ± 9.8 28.6 ± 2.9 
Resting ABP (mmHg)   
     SBP 115.2 ± 8.9 108.5 ± 12.7 
     DBP 67.6 ± 5.3 70.5 ± 8.9 
HR (beats/min) 68.3 ± 8.4 63.4 ± 15.9 
Medication: (n) 
   Diuretic 1 1 
   ACE 0 1 
   ARB 1 0 
   CCB 1 1 
   Diuretic + ACE 1 0 
   ACE + BB 0 1 
   ARB + BB 1 0 
   Diuretic + ACE + BB 0 1 
   Diuretic + ARB + CCB + BB  1 0 
Values are mean ± S.D.; all P > 0.05. 
 
 
Effects of IHG training on 24-hour ambulatory ABP 
 
Small reductions in 24-hour mean SBP, DBP and HR for the training group were 
noted, however, these findings were not statistically significant when compared to the 
non-exercising control group (all P > 0.05) at any time point. For 24-hour mean SBP, 
there was a trend towards a group and time interaction (P = 0.07) over the 8 week 
period. Nighttime SBP, DBP and HR did not significantly change from baseline (all P > 
0.05) for either group with 4- or 8- weeks of IHG training, yet, again, there was a trend 
towards a group x time interaction for a reduction in nighttime SBP (P = 0.06) over the 
entire training period (8-weeks). For both groups, daytime SBP, DBP, and HR remained 
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unchanged after 4- and 8-weeks of IHG training (all P > 0.05). All ambulatory ABP 
results are shown in Table 6. 
Table 6: 24-hour mean SBP and DBP at baseline, after 4- and 8-weeks of training. 
Variables Baseline 
After 4-weeks of 
training 
After 8- weeks of 
training 
 24-hour mean SBP (mmHg)    
    Control Group 126.2 ± 10.4 130.4 ± 8.5 127.9 ± 9.5 
    Training Group 127.4 ± 10.1 125.6 ± 8.9 125.5 ± 8.6 
 24-hour mean DBP (mmHg)    
     Control Group 71.4 ± 7.8 74.2 ± 8.4 71.7 ± 7.14 
     Training Group 76 ± 6.0 75.6 ± 6.0 74.4 ± 6.0 
24-hour mean HR (beats/min)    
     Control Group 62.8 ± 10.1 63.0 ± 8.5 62.2 ± 10.4 
     Training Group 68.3 ± 9.5 67.1 ± 9.7 67.6 ± 10.3 
Daytime SBP (mmHg)    
    Control Group 130.6 ± 11.5 134.0 ± 10.6 133.1 ± 10.9 
    Training Group 132.0 ± 8.8 130.5 ± 7.6 131.1 ± 8.9 
Daytime DBP (mmHg)    
     Control Group 75.1 ± 8.9 76.3 ± 9.5 75.2 ± 8.0 
     Training Group 80.0 ± 6.2 79.6 ± 6.8 79.5 ± 7.3 
Daytime HR (beats/min)    
     Control Group 66.2 ± 10.8 65.8 ± 9.3 64.4 ± 10.4 
     Training Group 71.3 ± 10.7 69.6 ± 11.1 71.0 ± 10.5 
Nighttime SBP (mmHg)    
    Control Group 117.9 ± 8.7 123.4 ± 7.7 119.0 ± 7.9 
    Training Group 120.0 ± 13.9 116.6 ± 12.5 116.0 ± 8.5 
Nighttime DBP (mmHg)    
     Control Group 65.1 ± 6.5 69.9 ± 6.9 64.7 ± 6.6 
     Training Group 69.2 ± 7.3 67.8 ± 6.1 65.6 ± 5.6 
Nighttime HR (beats/min)    
     Control Group 56.6 ± 9.3 57.4 ± 8.2 58.4 ± 10.5 
     Training Group 63.4 ± 9.6 62.5 ± 10.0 61.8 ± 9.6 
Values are mean ± S.D.; all P > 0.05. N = 20 (training group: n = 11; control group: n = 9). 
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Effects of IHG training resting HRV 
 
 
Following 4- and 8-weeks of IHG training, no significant differences were 
observed, in any indices of HRV (VLF, LF, HF, TP, LF: HF ratio and HF: TP ratio; all P > 
0.05). All data are presented in Table 7. 
 
Table 7: Resting HRV indices at baseline, after 4- and 8- weeks of training. 
 Baseline After 4-weeks of  
training 
After 8-weeks of   
training 
VLF (ms2) 
Training 
Control 
 
203.7 ± 275.0 
158.0 ± 122.7 
 
99.2 ± 86.0 
99.4 ± 86.2 
 
113.0 ± 132.0 
98.6 ± 107.7 
LF (ms2) 
Training 
Control 
 
86.9 ± 144.1 
108.2 ± 120.6 
 
50.7 ± 33.6 
76.2 ± 64.3 
 
47.7 ± 48.3 
47.7 ± 61.3 
HF (ms2) 
Training 
Control 
 
65.0 ± 103.6 
93.0 ± 124.0 
 
102.7 ± 119.6 
41.5 ± 33.2 
 
83.8 ± 109.1 
73.1 ± 91.5 
TP (ms2) 
Training 
Control 
 
355.6 ± 486.7 
359.2 ± 323.7 
 
252.7 ± 211.8 
217.1 ± 124.1 
 
244.4 ± 252.6 
219.4 ± 172.9 
LF/HF (ms2) 
Training 
Control 
 
2.1 ± 2.1 
3.1 ± 6.1 
 
0.8 ± 0.8 
3.8 ± 4.9 
 
3.2 ± 5.6 
1.6 ± 2.5 
HF/TP (ms2) 
Training 
Control 
 
0.3 ± 0.2 
0.2 ± 0.1 
 
0.4 ± 0.2 
0.2 ± 0.2 
 
0.4 ± 0.3 
0.3 ± 0.3 
  Values are mean ± S.D.; all P > 0.05. N = 18 (training group: n = 9; control group n = 9). 
 
Discussion: 
 Numerous small-scale studies in individuals with and without HT have 
investigated the effects of IHG training induced reductions in ABP, yet no randomized 
control trial to date has investigated its effects targeting solely medicated hypertensives. 
As 68% of individuals diagnosed with HT are receiving pharmacotherapy to treat their 
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HT, research focusing on this population is warranted. Secondly, no studies have 
investigated the effects of IHG training on ambulatory ABP, a clinically significant 
measure that provides a more comprehensive understanding of CVD risk (7). 
Furthermore, only one study has investigated the effects of IHG training on HRV, an 
important predictor of CVD related mortality (3,10,16,32), yet, many of the individuals in 
this study were not on medication for HT. Therefore, this study aimed to answer the 
novel questions: in medicated hypertensives 1) Does IHG training reduce resting ABP? 
2) Does IHG training improve ambulatory ABP? and, 3) Does IHG training improve 
resting HRV?   
Effects of IHG training on resting ABP and HR 
  Though the current study found small resting SBP reductions (~1 mmHg) for the 
training group, these findings did not reach statistical significance. The lack of SBP 
change was contrary to our hypothesis, and to the weight of published IHG studies in 
hypertensive individuals (25,35). Although reductions in resting DBP were not observed, 
these findings are in line with some of the current IHG literature. For example, Taylor and 
colleagues (35) reported significant reductions in resting SBP (~19 mmHg), but no 
significant reductions in DBP in older individuals with HT (mean resting ABP: ~156/82 
mmHg; many of whom were unmedicated) following 10-weeks of IHG training (35). In 
accordance with findings from Taylor and colleagues, McGowan and colleagues, using a 
with-in subject study design, investigated the effects of IHG training on a group of 
medicated hypertensives (mean resting ABP: ~134/73 mmHg) and found reductions in 
SBP (~15 mmHg) and no significant reductions in DBP. Although numerous IHG studies 
in normotensive individuals cite post-training reductions in DBP (20,37), the discrepancy 
in DBP finding between the current study and the normotensive studies may likely be 
due to protocol differences, suggesting the IHG training stimulus over 8-weeks may not 
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be sufficient to alter DBP in hypertensives. Alternatively, as a multilevel analysis 
performed to amalgamate previous IHG training studies performed in individuals with 
hypertension (25) showed a combined post-training DBP reduction of  ~3 mmHg, it is 
possible that greater numbers of participants are required to detect a statistically 
significant reduction in DBP. 
Why did we not replicate previously observed reductions in resting SBP in our 
population of medicated hypertensives? The lack of a reduction in SBP may be attributed 
to: 1) initial resting ABP, 2) IHG protocol, and/or 3) changes in physical activity and/or 
nutrition over the course of the study. As our study involved well-controlled medicated 
hypertensives (115/68 mmHg), the capacity for these individuals to respond to the IHG 
training stimulus may have been limited. Other studies that investigated the effects of 
IHG training in individuals with HT employed populations with higher initial ABPs, and as 
such, had a larger capacity for improvement (23,35). In support of this, a recent 
multilevel-analysis revealed that initial ABP had a significant effect on an individual’s 
ABP response to IHG training, with individuals with higher ABPs showing larger 
reductions in resting ABP (25). Protocol differences may have also played a role in the 
lack of an observed reduction in SBP. Hypertensive individuals who are receiving 
pharmacotherapy may require a larger (greater % MVC) and/or longer (timed 
contraction, number of contractions and/or length of training) IHG stimulus. Finally, 
physical activity and/or nutritional changes may have contributed to the lack of SBP 
reductions in this study however, we consider this unlikely as both were monitored 
throughout the investigation.  
As only 75% of individuals with HT experienced resting ABP reductions following 
exercise prescription (aerobic exercise training for 8 - 78 weeks, 2 - 6 times per week, at 
50 - 80% VO2max; 12), the training group was subdivided into individuals who responded 
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to IHG training (those that experience clinically significant IHG induced resting SBP 
reductions of ≥ 2 mmHg; 30) and those who did not respond (< 2 mmHg reduction in 
resting SBP). Although not statistically different, the responder group had higher baseline 
resting SBP (~6 mmHg) than those in the non-responding group. Again, this finding is in 
line with the weight of the evidence that suggests those with higher ABP experience the 
greatest hypotensive benefits from IHG training. There was also a marked difference, 
although not statistically significant, between the BMIs of the two groups. The responder 
group had a higher BMI (~36 kg/m2) than did the non-responder group (~29 kg/m2).  BMI 
is associated with a persons’ state of health, and as such, may have also played a role in 
their capacity to respond to an exercise intervention, as those in this study with higher 
BMIs experienced the greatest improvements in ABP following IHG training (24).  
Ambulatory ABP 
  This is the first study to investigate the effects of IHG training on ambulatory ABP. 
In the current study, no statistically significant improvements were observed for any 
component of ambulatory ABP (mean 24-hr, daytime, or nighttime), a finding of which 
was in contrast to our hypothesis. Though not statistically significant (although a trend 
was noted), clinically relevant reductions in mean 24-hr SBP (~3 mmHg) (30) were 
observed following IHG training. Higher ambulatory ABPs increase one’s risk of CVD (7), 
and as such, the reductions in mean 24-hour SBP in the current study may have the 
potential of reducing CVD risk (30). This reduction is in line with 24-hour mean 
ambulatory SBP reductions seen following aerobic exercise training (40 minutes of 
cycling, 3 times per week, for 10 weeks), though, like with IHG training, these reductions 
also did not achieve statistical significance (27).  
  For nighttime ambulatory SBP, the training group experienced post-training 
reductions that approached statistical significance, and thus the small size of the study 
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may have contributed to this finding. Alternatively, ambulatory activities were not 
controlled during the testing days at baseline, and after 4- and 8- weeks of training (or no 
training for the control group), and may have minimized the potential to observe 
significant changes, however, we consider this unlikely, as participants reported no 
changes in daily physical activities throughout the course of the investigation. 
Resting HRV 
  This investigation showed no significant improvement in any indices of HRV with 
IHG training. These finding are in contrast to our hypothesis that individuals would 
experience an improvement in HRV with IHG training, and contradict the findings of 
Taylor and colleagues (35), who noted marked improvements in vagal modulation of HR, 
in hypertensives, following 10-weeks of IHG training. An important distinction between 
the current study and the previously discussed study is that although both populations 
involved individuals with HT, in our study, all of our population was receiving 
pharmacotherapy for their HT. Autonomic function is known to improve with the 
prescription of ACE inhibitors and BBs (15,18), as these medications affect the 
autonomic nervous system. As participants in the study by Taylor and colleagues (35) 
were not all on HT medications, as a group they may have had a greater capacity to 
experience IHG training induced improvements in autonomic function. Furthermore, 
these individuals had hypertensive resting ABPs (> 150/80 mmHg), which suggests less 
effective control of resting ABP with pharmacotherapy, thus permitting a greater ABP 
and autonomic change with IHG training. As most of the individuals in this study were on 
an ACE inhibitor or BB, or a combination of an ACE inhibitor and a BB, they may have 
experienced maximum autonomic improvements from the pharmacotherapy and thus 
were unable to respond and/or had a blunted response to IHG training.  
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Conclusions and Future Directions: 
  These findings suggest individuals who are treated to within the normal ABP 
range (≤ 120/80 mmHg) may not experience ABP and HRV benefits from IHG training. 
Future studies should concentrate on populations of medicated and/or unmedicated 
hypertensives with ABPs above the normal range. Large scale trials aimed at these 
populations are necessary as they may reveal significant alterations in ABP, particularly 
ambulatory ABP, as our data suggests clinically relevant post-training improvements in 
ambulatory SBP (mean 24-hour and nighttime). This finding provides vital information 
regarding the limitations of assessing resting ABP alone, as the current study found no 
reductions in resting ABP. As ambulatory ABP is a better predictor of morbidity and 
mortality than resting ABP (7), it is important that future studies measure ambulatory 
ABP in addition to resting ABP. 
 Furthermore, the ability to classify individuals as responders or non-responders would 
provide effective and timely treatment regimes for HT individuals. Currently, only one 
study has investigated the predictability of IHG training success using cardiovascular 
reactivity tasks in normotensive individuals (26). Such studies should be conducted in 
hypertensives to establish whether this is an efficacious way of predicting IHG training 
hypotensive responses. Future studies should also aim to further stratify medication 
regimens to help provide a broader understanding of the effects of medication, alone or 
in combination, on the ABP and HRV responses to IHG exercise. 
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CHAPTER 5: General Discussion 
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 CVD is the leading cause of death in Canada, with HT significantly contributing 
to the risk of its development. HT is a complex pathophysiological disease, which rarely 
can be attributed to a known cause. Individuals with HT have elevated resting and 
ambulatory ABP experience PEH following many forms of exercise, and have reduced 
HRV.  
The prevention and treatment of HT include lifestyle modifications and 
pharmacotherapy. Many individuals treated with pharmacotherapy are treated to within 
the normal ABP range, yet others remain unaffected (7). Lifestyle modifications, 
particularly exercise, have proven to be a successful means of lowering resting and 
ambulatory ABP (4,5,8) and improving HRV (1,2,3).  
IHG training is a novel, less time consuming, simple exercise, shown, in 
individuals with and without HT, to markedly reduce resting ABP (6). The transfer of 
these effects to activities of daily living (i.e., ambulatory ABP), however, is currently 
unknown. Furthermore, individuals with HT have shown improvements in HRV with IHG 
training (8); however, the PEH and HRV responses post-IHG in HT individuals remain 
unknown, as are the effects of training on these responses.  
 The overall aim of this thesis was to answer the following research questions:  
1) Does a bout of IHG elicit a PEH response and improvements in vagal modulation of 
HR in individuals medicated for HT, and do these responses change with 8-weeks of 
IHG training? and, 2) Does IHG training reduce resting ABP and 24-hour ambulatory 
ABP and improve vagal modulation of HR in medicated hypertensive? 
 Research Question 1: Does a bout of IHG elicit a PEH response and improve 
vagal modulation of HR in individuals medicated for HT, and do these responses change 
with 8-weeks of IHG training? 
 110 
 Our investigation found that a bout of IHG did not elicit a PEH response nor did it 
improve vagal modulation of HR. Following 4- and 8-weeks of training, the observed 
ABP and HRV responses were unchanged, and remarkably, they remained similar to the 
ABP and HRV responses observed at baseline, demonstrating a sustained response to 
IHG exercise.  
 Research Question 2: Does IHG training reduce resting and 24-hour ambulatory 
ABP and improve vagal modulation of HR in medicated hypertensive? 
 This investigation found no resting ABP or ambulatory ABP reductions following 4- 
or 8-weeks of IHG training, and all indices of HRV, including vagal HR modulation, were 
also unaltered with IHG training.  
The population in this study was one of well-controlled medicated hypertensive 
individuals with ABPs within the normal range. These individuals may have experienced 
the maximum improvements in ABP and HRV with their HT medications, which may 
have limited their acute post-IHG responses, as well as their IHG training responses.  
The IHG exercise stimulus may not have been great enough to elicit a PEH 
response or alterations in HRV following acute IHG exercise, or following IHG training in 
well-controlled medicated hypertensives. For this population, a greater stimulus (> 30% 
MVC), a longer duration of the sustained contractions (> 2-minutes) or their frequency (> 
4 contractions), and/or a longer intervention period (> 8 weeks) may be needed to elicit 
the anticipated responses. 
The results of this study should be interpreted with caution, as many individuals 
in the general population with HT are not controlled to within the ABP normal ranges. 
The participants in this study were among the 64% of those who are effectively 
controlled with medication for their HT, and as such, do not provide an accurate 
representation of the general hypertensive population.  
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 In summary, the primary findings of this investigation are: 1) IHG exercise does not 
elicit an acute PEH response nor does it alter post-IHG HRV in well-controlled medicated 
hypertensives, and these responses are unchanged with IHG training, and, 2) IHG 
training does not significantly reduce resting or ambulatory ABP, nor does it improve 
indices of HRV at rest in this population. 
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Appendix A 
 
 
 
Individuals on Medication for HIGH BLOOD PRESSURE are 
invited to participate in a Research Study 
 
 
Dr. McGowan and Cassandra Stiller-Moldovan at the University of Windsor are currently 
looking for individuals to participate in a study, approved by the Research Ethics Board, 
examining the effects of handgrip exercise on individuals medicated for high blood 
pressure. 
 
 
We invite people who:  
• Have high blood pressure 
• Are on medication for high blood pressure 
If you are interested and would like more information please contact: 
Cassandra Stiller-Moldovan: (519)-253-3000 ext. 4979 
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Appendix B 
 
Radio Advertisement: 
 
Attention individuals with high blood pressure. If you are currently on medication for high 
blood pressure you may be eligible to participate in a research study at the University of 
Windsor conducted by Dr. McGowan and Cassandra Stiller-Moldovan. For more 
information please contact: Cassandra Stiller-Moldovan at 519-253-3000, ext 4979. 
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Appendix E 
 
 
       
LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN RESEARCH 
 
 
Title of Study: The effects of isometric handgrip exercise on post-exercise hypotension and heart rate 
variability in individuals medicated for hypertension. 
 
You are asked to participate in a research study conducted by Ms. Cassandra Stiller-Moldovan and Dr. 
Cheri McGowan, from the Department of Kinesiology at the University of Windsor. Ms. Cassandra Stiller-
Moldovan will be using this study to conduct research for her pursuit of a master’s degree in Human 
Kinetics. 
 
If you have any questions or concerns about the research, please feel to contact Dr. Cheri McGowan 
(faculty supervisor) at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca 
 
PURPOSE OF THE STUDY 
 
The main purpose of this study is to examine the blood pressure response immediately after a bout of 
isometric handgrip exercise in people who are taking medication to control their high blood pressure. We are 
also interested in seeing if this changes after 8 weeks of using the handgrip 3X per week. We also expect 
isometric handgrip training to lower your resting blood pressure, and to improve how your heart varies its 
rhythm.   
 
PROCEDURES 
 
If you volunteer to participate in this study, we would ask you to do the following things: 
 
Eligibility/Consent/Familiarization Procedures 
 
Visit 1: 
 
After expressing interest in the study, if you meet the inclusion criteria, you will be invited to meet the 
investigators at the Applied Human Performance Laboratory (Department of Kinesiology, University of 
Windsor). At that time, you will be asked to read the consent form and information sheet on the study. After 
meeting with Ms. Cassandra Stiller-Moldovan and Dr. Cheri McGowan (study investigators), you will be 
familiarized with all portions of the investigation. If you are still interested in participating in the study, you will 
be asked to sign the consent form. Once you have given consent, you will fill out a brief medical 
questionnaire.  At this time, we encourage you to ask any questions you have. 
 
Visit 2: 
 
To familiarize you with the procedures involved, you will undergo practice testing of resting blood pressure 
and heart rate acquisition. After this information has been collected, you will be randomized into one of two 
groups: 1) isometric handgrip training group, or 2) the control group (non-exercising). If you are randomized 
to the isometric handgrip training group, you will be shown how to properly perform a bout of isometric 
handgrip exercise. You will continue this exercise program for 8 weeks. If you are randomized to the control 
group, you will not exercise during the 8 week training period. 
 
Measurement Procedures- 3rd visit to completion of investigation: 
 
If you are randomized to the isometric handgrip group or the control group, you will undergo the same 
testing procedures. Testing will take place over 2 days before you start the study, in the Applied Human 
Performance Laboratory (Department of Kinesiology, University of Windsor). These procedures will be 
repeated in all participants after 4 week and 8 week of training. All measurements will take place in the 
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morning in a quiet, temperature-controlled room after a light, standardized breakfast (e.g., you will eat the 
same breakfast before each testing session), and you will take your medication at the same time. To 
minimize the influence of outside factors on these measures, you will be asked to avoid drinking alcohol and 
exercising for 24 hours before each testing session, as well as avoiding caffeine for 12-hours before the 
testing session. Your blood pressure medication will be monitored throughout the study, including your 
dosage, and the time of day you take the medication. Should your blood pressure medication change (dose, 
addition or removal of a medication) during the study, you must let one of the investigators know, and your 
results will be removed from the study. However, you may stay in the study until it is complete.   
 
Day 1 (approximately 1 hour): After 10 minutes of seated rest, your resting blood pressure will be measured. 
We will take your blood pressure using a method that is similar to the way your doctor takes your blood 
pressure in their office. You will then participate in two tasks. The first will involve you placing your hand in 
cold water for 2 minutes. After this task, you will rest for 10 minutes in a seated position. Next, you will 
perform the second task, which involves mental arithmetic. You will be asked to subtract a 2-digit number 
from a number presented to you and say your answer aloud. You will be shown a total of 25 numbers, and 
will be given 5 seconds to complete each number. Following these tests, you will be sent home with a blood 
pressure device that will monitor your blood pressure for the next 24-hours. You will return the device the 
following morning.    
 
Day 2 (approximately 3.5 hours): After 10 minutes of seated rest, your resting blood pressure will be 
measured, in the same way as it was on Day 1. Heart rate will be measured using standard 
electrocardiography, whereby a set of 3 electrodes will be placed on your chest. Heart rate will be recorded 
for 10 minutes. Following this data collection period, you will perform a bout of isometric handgrip exercise: 
you will perform 4 sets of 2-minute hand squeezing exercises (using alternate hands) on a programmed 
handgrip device at 30% of your maximum squeezing ability (which will be determined at the beginning of 
each exercise session with the handgrip device), separated by 1-minute rest intervals. During this exercise 
protocol, your heart rate will be recorded.  Immediately following the last rest period, we will record your 
heart rate for 10 minutes. Following an additional 5-minute rest period, your blood pressure will be recorded. 
Your blood pressure will again be evaluated after 1 hour and 2 hours following the exercise session. 
Following the final blood pressure evaluation, we will send you home will a device that will record your blood 
pressure for the next 24 hours. The morning following the Day 2 testing session, you will return this device. 
 
If you are randomized to the handgrip exercise group, you will train 3 times per week, for a total of 8 weeks. 
Two training sessions per week will take place under the supervision of an exercise trainer, where your 
resting blood pressure will be acquired, before each session, and the third session will be conducted in the 
your home. You will be provided with detailed instructions to ensure proper at home training, and will be 
instructed to record your exercise, nutritional, and medication data in exercise log books we will provide for 
you. If you are randomized to the control group, you will visit the laboratory 2 times per week for resting 
blood pressure measurements, for a total of 8 weeks. 
 
Everyone will undergo identical testing procedures, which will occur on week 5, and week 9 of the study. 
 
As mentioned above, you will be assigned to a handgrip exercise or a control group through random 
assignment. Testing visits will range between 30 minutes and 3.5 hours. For those randomized to the 
handgrip training group, training sessions will last no more than 30 minutes. 
 
Visits to the University of Windsor for testing will take place during week 1, week 5,  and week 9 of this 
study. You will be given a schedule of events for the study, to ensure your understanding and availability. 
You will be notified via email and/or phone call for follow-up sessions.  
 
POTENTIAL RISKS AND DISCOMFORTS 
 
If you are assigned to the handgrip training group, you may experience tendonitis in the trained tendons, 
however this risk is minimal if the exercise is properly performed. The blood pressure measurement 
procedure is non-invasive, as is electrocardiography for acquiring heart rate. However, in rare instances, you 
may experience numbness and/or tingling in the occluded limb while we are measuring your blood pressure 
and/or a minor rash from the heart electrode stickers we use to measure your heart rate. 
 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
You may or may NOT experience a lower resting blood pressure by participating in this study.  
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PAYMENT FOR PARTICIPATION 
 
Subjects will not receive payment for participation in this study. 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified with you will remain 
confidential and will be disclosed only with your permission. 
 
To ensure anonymity of subjects, following consent, all participants will be assigned an identification 
number. To ensure confidentiality, no mention of subject names will be used in any publication or 
presentation, and participants will be identified only by their identification number on all collection tools 
(electronic or otherwise). All paper data will be stored in a locked filing cabinet in the locked office of the 
principal investigators (HK 133, Department of Kinesiology, University of Windsor), and all electronic data 
will be stored in a locked laboratory (Applied Human Performance Laboratory, Department of Kinesiology, 
University of Windsor). Information stored on computer will be password-accessible only, and will be 
available only to the study investigators. With respect to final disposal, all paper records (including medical 
questionnaires) will be shredded. 
 
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you may withdraw at 
any time without consequences of any kind.  You may also refuse to answer any questions you don’t want to 
answer and still remain in the study.  The investigator may withdraw you from this research if circumstances 
arise which warrant doing so.  
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
 
Subjects will have the option of receiving results from the study either by mail or email. Results will also be 
posted on the REB website in April 2010. 
 
 
Web address: http://www.uwindsor.ca/reb 
Date when results are available:    April 2010 
 
SUBSEQUENT USE OF DATA 
 
This data may be used in subsequent studies. As data will be collected under the subject’s identification 
number, data used for ongoing studies will ensure the privacy of the subjects.  
 
 
RIGHTS OF RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without penalty. If you have 
questions regarding your rights as a research subject, contact: Research Ethics Coordinator, University of 
Windsor, Windsor, Ontario N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail:  ethics@uwindsor.ca 
 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
 
 
_____________________________________   ____________________ 
Signature of Investigator      Date 
 
 
Revised February 2008 
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Appendix F 
 
 
 
CONSENT TO PARTICIPATE IN RESEARCH 
 
 
Title of Study: The effects of isometric handgrip exercise on post-exercise hypotension and heart rate 
variability in individuals medicated for hypertension. 
 
You are asked to participate in a research study conducted by Ms. Cassandra Stiller-Moldovan and Dr. 
Cheri McGowan, from the Department of Kinesiology at the University of Windsor. Ms. Cassandra Stiller-
Moldovan will be using this study to conduct research for her pursuit of a master’s degree in Human 
Kinetics. 
 
If you have any questions or concerns about the research, please feel to contact Dr. Cheri McGowan 
(faculty supervisor) at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca 
 
PURPOSE OF THE STUDY 
 
The main purpose of this study is to examine the blood pressure response immediately after a bout of 
isometric handgrip exercise in people who are taking medication to control their high blood pressure. We are 
also interested in seeing if this changes after 8 weeks of using the handgrip 3X per week. We also expect 
isometric handgrip training to lower your resting blood pressure, and to improve how your heart varies its 
rhythm.   
 
PROCEDURES 
 
If you volunteer to participate in this study, we would ask you to do the following things: 
 
Eligibility/Consent/Familiarization Procedures 
 
Visit 1: 
 
After expressing interest in the study, if you meet the inclusion criteria, you will be invited to meet the 
investigators at the Applied Human Performance Laboratory (Department of Kinesiology, University of 
Windsor). At that time, you will be asked to read the consent form and information sheet on the study. After 
meeting with Ms. Cassandra Stiller-Moldovan and Dr. Cheri McGowan (study investigators), you will be 
familiarized with all portions of the investigation. If you are still interested in participating in the study, you will 
be asked to sign the consent form. Once you have given consent, you will fill out a brief medical 
questionnaire.  At this time, we encourage you to ask any questions you have. 
 
Visit 2: 
 
To familiarize you with the procedures involved, you will undergo practice testing of resting blood pressure 
and heart rate acquisition. After this information has been collected, you will be randomized into one of two 
groups: 1) isometric handgrip training group, or 2) the control group (non-exercising). If you are randomized 
to the isometric handgrip training group, you will be shown how to properly perform a bout of isometric 
handgrip exercise. You will continue this exercise program for 8 weeks. If you are randomized to the control 
group, you will not exercise during the 8 week training period. 
 
Measurement Procedures- 3rd visit to completion of investigation: 
 
If you are randomized to the isometric handgrip group or the control group, you will undergo the same 
testing procedures. Testing will take place over 2 days before you start the study, in the Applied Human 
Performance Laboratory (Department of Kinesiology, University of Windsor). These procedures will be 
repeated in all participants after 4 week and 8 week of training. All measurements will take place in the 
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morning in a quiet, temperature-controlled room after a light, standardized breakfast (e.g., you will eat the 
same breakfast before each testing session), and you will take your medication at the same time. To 
minimize the influence of outside factors on these measures, you will be asked to avoid drinking alcohol and 
exercising for 24 hours before each testing session, as well as avoiding caffeine for 12-hours before the 
testing session. Your blood pressure medication will be monitored throughout the study, including your 
dosage, and the time of day you take the medication. Should your blood pressure medication change (dose, 
addition or removal of a medication) during the study, you must let one of the investigators know, and your 
results will be removed from the study. However, you may stay in the study until it is complete.   
 
Day 1 (approximately 1 hour): After 10 minutes of seated rest, your resting blood pressure will be measured. 
We will take your blood pressure using a method that is similar to the way your doctor takes your blood 
pressure in their office. You will then participate in two tasks. The first will involve you placing your hand in 
cold water for 2 minutes. After this task, you will rest for 10 minutes in a seated position. Next, you will 
perform the second task, which involves mental arithmetic. You will be asked to subtract a 2-digit number 
from a number presented to you and say your answer aloud. You will be shown a total of 25 numbers, and 
will be given 5 seconds to complete each number. Following these tests, you will be sent home with a blood 
pressure device that will monitor your blood pressure for the next 24-hours. You will return the device the 
following morning.    
 
Day 2 (approximately 3.5 hours): After 10 minutes of seated rest, your resting blood pressure will be 
measured, in the same way as it was on Day 1. Heart rate will be measured using standard 
electrocardiography, whereby a set of 3 electrodes will be placed on your chest. Heart rate will be recorded 
for 10 minutes. Following this data collection period, you will perform a bout of isometric handgrip exercise: 
you will perform 4 sets of 2-minute hand squeezing exercises (using alternate hands) on a programmed 
handgrip device at 30% of your maximum squeezing ability (which will be determined at the beginning of 
each exercise session with the handgrip device), separated by 1-minute rest intervals. Immediately following 
the last rest period, we will record your heart rate for 10 minutes. Following an additional 5-minute rest 
period, your blood pressure will be recorded. Your blood pressure will again be evaluated after 1 hour and 2 
hours following the exercise session. Following the final blood pressure evaluation, we will send you home 
will a device that will record your blood pressure for the next 24 hours. The morning following the Day 2 
testing session, you will return this device. 
 
If you are randomized to the handgrip exercise group, you will train 3 times per week, for a total of 8 weeks. 
Two training sessions per week will take place under the supervision of an exercise trainer, where your 
resting blood pressure will be acquired, before each session, and the third session will be conducted in the 
your home. You will be provided with detailed instructions to ensure proper at home training, and will be 
instructed to record your exercise, nutritional, and medication data in exercise log books we will provide for 
you. If you are randomized to the control group, you will visit the laboratory 2 times per week for resting 
blood pressure measurements, for a total of 8 weeks. 
 
Everyone will undergo identical testing procedures, which will occur on week 5, and week 9 of the study. 
 
As mentioned above, you will be assigned to a handgrip exercise or a control group through random 
assignment. Testing visits will range between 30 minutes and 3.5 hours. For those randomized to the 
handgrip training group, training sessions will last no more than 30 minutes. 
 
Visits to the University of Windsor for testing will take place during week 1, week 5,  and week 9 of this 
study. You will be given a schedule of events for the study, to ensure your understanding and availability. 
You will be notified via email and/or phone call for follow-up sessions.  
   
POTENTIAL RISKS AND DISCOMFORTS 
 
If you are assigned to the handgrip training group, you may experience tendonitis in the trained tendons, 
however this risk is minimal if the exercise is properly performed. The blood pressure measurement 
procedure is non-invasive, as is electrocardiography for acquiring heart rate. However, in rare instances, you 
may experience numbness and/or tingling in the occluded limb while we are measuring your blood pressure 
and/or a minor rash from the heart electrode stickers we use to measure your heart rate. 
 
 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
You may or may NOT experience a lower resting blood pressure by participating in this study.  
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PAYMENT FOR PARTICIPATION 
 
You will not receive payment for their participation in this study. 
 
 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified with you will remain 
confidential and will be disclosed only with your permission. 
 
To ensure anonymity of subjects, following consent, all participants will be assigned an identification 
number. To ensure confidentiality, no mention of subject names will be used in any publication or 
presentation, and participants will be identified only by their identification number on all collection tools 
(electronic or otherwise). All paper data will be stored in a locked filing cabinet in the locked office of the 
principal investigators (HK 133, Department of Kinesiology, University of Windsor), and all electronic data 
will be stored in a locked laboratory (Applied Human Performance Laboratory, Department of Kinesiology, 
University of Windsor). Information stored on computer will be password-accessible only, and will be 
available only to the study investigators. With respect to final disposal, all paper records (including medical 
questionnaires) will be shredded. 
 
PARTICIPATION AND WITHDRAWAL 
 
You can choose whether to be in this study or not.  If you volunteer to be in this study, you may withdraw at 
any time without consequences of any kind.  You may also refuse to answer any questions you do not want 
to answer and still remain in the study.  The investigator may withdraw you from this research if 
circumstances arise which warrant doing so. 
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
 
Subjects will have the option of receiving results from the study either by mail or email. Results will also be 
posted on the University of Windsor’s Research Ethics Board (REB) website in April 2010. 
 
 
Web address: http://www.uwindsor.ca/reb 
Date when results are available: April 2010 
 
SUBSEQUENT USE OF DATA 
 
This data may be used in subsequent studies. As data will be collected under the subject’s identification 
number, data used for ongoing studies will ensure the privacy of the subjects.  
 
 
RIGHTS OF RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without penalty. If you have 
questions regarding your rights as a research subject, contact:  Research Ethics Coordinator, University of 
Windsor, Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: ethics@uwindsor.ca 
 
 
SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE 
 
I understand the information provided for the study “The effects of isometric handgrip exercise on post-
exercise hypotension and heart rate variability in individuals medicated for hypertension” as described 
herein.  My questions have been answered to my satisfaction, and I agree to participate in this study.  I have 
been given a copy of this form. 
 
______________________________________ 
Name of Subject 
 
______________________________________   ___________________ 
Signature of Subject       Date 
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SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
 
_____________________________________   ____________________ 
Signature of Investigator      Date 
Revised February 2008 
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Appendix G 
 
Medical Questionnaire 
Last Name________________________   First Name____________________________ 
Address________________________   City __________________   Province _________________ 
Sex (please circle):  M     F         Height:_____________________   Weight: ___________________ 
Date of Birth_________    Home Phone #   (             ) ______   Postal Code ________________  
                   Month     Year 
FOR EMERGENCY NOTIFY:  Name______________________  Relationship_________________ 
Address____________________________________  Phone______________________________ 
Family Doctor's Name_____________________  Date of Last Physical _____________________ 
                                                                                                                               Month     Year  
   
Please Check Yes or No:                                                                                                      Yes     No  
1. Have you ever been hospitalized? --------------------------------------------------------------------------o       o 
          If yes, please specify? 
          ________________________________________________________ 
 Have you ever had surgery? ---------------------------------------------------------------------------------o        o 
         If yes, please specify?  
         ________________________________________________________ 
2. Are you presently taking any medications or pills (including aspirin)?---------------------------- o         o 
         If yes, please specify?  
               ________________________________________________________ 
 Are you presently taking any vitamins or supplements?---------------------------------------------- o        o 
3. Do you have any allergies (medicine, food, bees or other stinging insects)?-------------------  o        o 
         If yes, please specify?  
         ________________________________________________________ 
4. Have you ever passed out during or after exercise?---------------------------------------------------  o       o 
 Have you ever been dizzy during or after exercise?---------------------------------------------------  o       o 
 Have you ever had chest pain during or after exercise?----------------------------------------------  o       o 
 Do you have high blood pressure?-------------------------------------------------------------------------  o       o 
If yes, are you being treated for this condition? 
       ________________________________________________________        
 Have you ever been told that you have a kidney problem? ----------------------------------------- o       o 
 Have you ever been told that you have joint instability? --------------------------------------------- o       o 
       Have you ever been told that you have a stomach problem? -------------------------------------- o       o 
       Have you ever been told that you have a heart problem? ------------------------------------------  o       o 
       Have you ever been told that you have a heart murmer? ------------------------------------------- o       o 
 Do you have a machine that regulated your heart beat? -------------------------------------------- o       o 
       Have you ever had racing of your heart or skipped heartbeats? ---------------------------------- o       o 
 Has anyone in your family died of heart problems or a sudden death before age 50? ------ o       o 
5. Do you have any skin problems (itching, rashes, acne)? -------------------------------------------  o       o 
       If you get a cut, does it take you a long time to stop bleeding?------------------------------------- o      o  
 If you experience a blow to a muscle, to you bruise easily? ---------------------------------------- o      o  
6. Do you have Diabetes? -------------------------------------------------------------------------------------- o       o 
7. Do you have Asthma or any other breathing problems? --------------------------------------------  o       o 
               If yes, please specify?  
               ________________________________________________________ 
 125 
8. Do you have any type of cardiovascular disease? ---------------------------------------------------- o       o 
         If yes, please specify?  
         ________________________________________________________ 
9. Have you had any other medical problems (infectious mononucleosis, etc.)? -----------------o       o 
10. Have you had any medical problems since your last physical? ------------------------------------o       o 
11. Do you smoke? -------------------------------------------------------------------------------------------------o       o 
Please explain any physical limitations that may prevent you from completing this study. 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
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Appendix H 
 ________________________________________________________________________________     
 
 
 
At HOME JOURNAL:    
 
Subject ID:____________________________________________________________ 
 
Date What was 
your 
maximum 
contraction 
value? 
Did you 
complete 
two sets 
with 
each 
hand? 
Time you 
took your 
medication 
Have you 
had any 
medication 
changes? If 
yes, please 
describe. 
Have you 
had any 
dietary 
changes? If 
yes, please 
describe. 
Have you 
had any 
physical 
activity 
changes? 
If yes, 
please 
describe. 
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